Next Article in Journal
Volatile Essential Oils from Different Tree Species Influence Scent Impression and Physiological Response
Previous Article in Journal
Effective Ciprofloxacin Removal from Deionized and Salt Water by Sulfonated Pentablock Copolymer (NexarTM)
Previous Article in Special Issue
The General Principle of the Warburg Effect as a Possible Approach for Cancer Immunotherapy: The Regulatory Effect of Plant Extracts Could Change the Game
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Medicinal Plants for Skin Disorders: Phytochemistry and Pharmacological Insights

by
Nazerke Bolatkyzy
1,
Daniil Shepilov
1,
Rakhymzhan Turmanov
2,
Dmitriy Berillo
3,
Tursunay Vassilina
4,
Nailya Ibragimova
5,
Gulzat Berganayeva
1,* and
Moldyr Dyusebaeva
1,*
1
Faculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, 71 Al-Farabi Avenue, Almaty 050042, Kazakhstan
2
Department of Chemistry, Abai Kazakh National Pedagogical University, Dostyk Avenue 13, Almaty 050010, Kazakhstan
3
Center of Agro Competence, M. Kozybayev North-Kazakhstan University, Petropavlovsk 150000, Kazakhstan
4
Kazakh National Agrarian Research University, St. Named After Valikhanov 137, Almaty 050000, Kazakhstan
5
Faculty of Engineering and Information Technologies, Kazakh-German University (DKU), Almaty 050010/A26C7F8, Kazakhstan
*
Authors to whom correspondence should be addressed.
Molecules 2025, 30(15), 3281; https://doi.org/10.3390/molecules30153281
Submission received: 27 June 2025 / Revised: 19 July 2025 / Accepted: 31 July 2025 / Published: 6 August 2025
(This article belongs to the Special Issue Bioactive Molecules in Medicinal Plants)

Abstract

Skin disorders are common and often chronic conditions with significant therapeutic challenges. Limitations of conventional treatments, such as adverse effects and antimicrobial resistance, have increased interest in plant-based alternatives. This article presents the phytochemical composition and pharmacological potential of several medicinal plants traditionally used in the treatment of skin diseases, including Rubus vulgaris, Plantago major, Artemisia terrae-albae, and Eryngium planum. Based on an analysis of scientific literature, the presence of bioactive compounds—including flavonoids, anthocyanins, phenolic acids, tannins, and sesquiterpenes—is summarized, along with their antioxidant, anti-inflammatory, and antimicrobial effects. Emphasis is placed on the correlation between traditional ethnomedicinal applications and pharmacological mechanisms. The findings support the potential of these species as sources for dermatological phytotherapeutics. Further research is needed to standardize active constituents, assess safety, and conduct clinical validation.

1. Introduction

Skin disorders are among the most prevalent health conditions worldwide and significantly affect patients’ quality of life. According to the European Academy of Dermatology and Venereology, up to 43% of the adult population in Europe suffers from at least one dermatological condition, including eczema, acne, psoriasis, dermatitis, and fungal skin infections [1]. These conditions are often accompanied by inflammation, itching, and impaired skin barrier function, and frequently manifest as chronic diseases. Moreover, they may lead to considerable psychological and social discomfort, particularly in cases of prolonged progression and visible cosmetic defects [2].
Modern dermatology offers a wide range of synthetic treatments, from topical corticosteroids to systemic immunomodulators. However, long-term use of these agents is frequently associated with adverse effects such as skin atrophy, hypopigmentation, resistance development, and microbiome disruption [3]. As a result, there is growing interest in the use of herbal medicines—plant-based therapeutics known for their mild action, favorable tolerability, and broad pharmacological effects [4].
Medicinal plants have been used for centuries in traditional healing systems such as Ayurveda, Traditional Chinese Medicine, European phytotherapy, and East Slavic folk medicine for managing various skin conditions, including ulcers, burns, eczema, and inflammatory dermatoses [5,6]. With the accumulation of scientific evidence on the chemical composition and mechanisms of action of plant extracts, their use has been increasingly integrated into evidence-based medicine. Many plants that were once used empirically are now included in officially registered dermatological and cosmeceutical formulations listed in international pharmacopoeias [7].
Plants possess a unique biochemical potential, including flavonoids, terpenoids, polysaccharides, phenolic acids, tannins, and essential oils, which exhibit a broad spectrum of biological activities relevant to skin health [8,9]. These phytocompounds have demonstrated the ability to modulate pro-inflammatory cytokine expression, inhibit key inflammatory enzymes such as cyclooxygenase-2 (COX-2), promote epidermal regeneration, and restore skin barrier integrity [10,11]. Such mechanisms are particularly relevant in the context of multifactorial dermatological conditions like acne vulgaris and psoriasis. The pathogenesis of acne involves hyperseborrhea, follicular hyperkeratinization, Cutibacterium acnes colonization, and cytokine-mediated inflammation (e.g., IL-1β, TNF-α), while psoriasis is characterized by Th1/Th17-mediated immune dysregulation, overexpression of IL-17, IL-23, and interferon-γ and keratinocyte hyperproliferation. These pathological mechanisms represent suitable therapeutic targets for phytochemicals exhibiting antioxidant, anti-inflammatory, antimicrobial, and immunomodulatory effects.
This review article presents a comprehensive analysis of medicinal plants used in the treatment of dermatological conditions, with a focus on their phytochemical composition, mechanisms of action, and recent pharmacological evidence. More than 30 plant species traditionally used in both folk and official medicine for managing eczema, dermatitis, psoriasis, burns, acne, trophic ulcers, and other skin disorders are discussed. This article also highlights the potential of integrating herbal remedies into dermatological and cosmeceutical formulations. Special attention is given to species used in Central Asian traditional medicine, selected based on historical usage combined with modern experimental validation of biological activities. The objective of this review is to synthesize existing knowledge on these species in the context of current pharmacological research and identify their translational potential for evidence-based dermatology.

2. Methodology of Literature Selection

The selection of plant species for this review was based on a combined ethnobotanical and pharmacological approach, with a particular focus on the traditional medical systems of Central Asia. Initial inclusion criteria prioritized plants historically used in regional ethnomedicine for the treatment of skin disorders such as wounds, burns, ulcers, dermatitis, eczema, and acne. Ethnopharmacological relevance was established through analysis of classical sources and field ethnobotanical surveys, with attention given to species showing consistent topical application across cultures and time periods.
Studies were included if they demonstrated skin-related activity in vitro or in vivo, including anti-inflammatory, antimicrobial, antioxidant, or regenerative effects. Older sources were used for historical or phytochemical background, while recent literature supported mechanistic and pharmacological analysis.
To maintain clarity and avoid redundancy, only one representative compound was selected for each plant species. These compounds were chosen based on either their quantitative predominance in the plant material or the frequency of their pharmacological assessment in the context of skin-related bioactivity. While each species may contain multiple active constituents, including structurally related compounds, this review focuses on those with the most evidence-based dermatological relevance.
The final list comprised twenty species selected for their documented ethnomedical use, presence of bioactive compounds relevant to skin health, and availability of modern experimental evidence. This methodology ensured that both traditional knowledge and contemporary scientific data were integrated to assess the dermatological potential of the selected medicinal plants.

3. Medicinal Plants

3.1. Bergenia crassifolia

Bergenia crassifolia, a perennial herbaceous plant belonging to the family Saxifragaceae, is native to Siberia, the Altai Mountains, Mongolia, China, and Korea. It typically grows on rocky slopes, screes, and within coniferous and deciduous forests, preferring shaded and moist habitats [12].
Phytochemical investigations of species within the Bergenia genus, including B. crassifolia and B. cordifolia, have revealed a high content of arbutin, flavonoids, hydroxycinnamic acids, polyphenols, and tannins—compounds known for their dermatological activity. Arbutin (Figure 1), the principal bioactive constituent of these plants, exerts a pronounced depigmenting effect by inhibiting tyrosinase, a key enzyme involved in melanin biosynthesis. High-performance liquid chromatography with ultraviolet detection (HPLC-UV) analysis showed that the arbutin content in the leaves of various Bergenia specimens ranged from 4.8 to 9.8 g/100 g, with the highest levels reported in samples collected from Finland.
In addition, substantial concentrations of polyphenolic compounds (up to 9.27 g/100 g), tannins (up to 6.7 g/100 g), and hydroxycinnamic acids (up to 2.42 g/100 g) underscore the potential therapeutic relevance of Bergenia species in the treatment of inflammatory and hyperpigmented skin conditions. The co-presence of arbutin and other phenolic constituents suggests a possible synergistic interaction, potentially enhancing the overall dermatological efficacy of Bergenia-based formulations (Figure 2) [13,14,15].
A study published in the Mongolian Journal of Chemistry investigated the wound-healing activity of a composition based on a hydrogel of poly(hexamethylene guanidine) hydrochloride combined with an extract of Bergenia crassifolia in a thermal burn model on laboratory animals. The results demonstrated that this formulation contributes to the normalization of antioxidant activity and leukocyte levels. Morphological analysis revealed that wound healing was significantly accelerated in the treatment group compared to the control, as evidenced by a reduction in the thickness of the leukocyte-necrotic eschar, enhanced epithelialization, and complete closure of the skin defect [16].
Bergenia crassifolia is also utilized in cosmetic products aimed at pore tightening, reducing oily skin shine, and overall improvement of skin condition. Decoctions and infusions prepared from its leaves and rhizomes are commonly applied in the form of lotions, facial rinses, and compresses. In clinical settings, Bergenia-based formulations are used in the treatment of burns and trophic ulcers as part of combination therapy, promoting epithelial regeneration and protecting damaged tissue from microbial infection [17,18,19].

3.2. Black Elderberry (Sambucus nigra)

Sambucus nigra is a perennial shrub belonging to the family Adoxaceae, widely distributed in the temperate regions of Europe, North Africa, and Western Asia. Its flowers and fruits have been traditionally and officially employed in medicine, including in dermatology and cosmetology applications [20,21].
The flowers of S. nigra contain flavonoids (notably rutin (Figure 3) and quercetin), essential oils, organic acids (such as malic, acetic, and valeric acids), tannins, and mucilaginous compounds. The fruits are rich in anthocyanins, vitamin C, B-complex vitamins, sugars, pectins, and carotenoids. Due to this diverse phytochemical profile, Sambucus-based preparations exhibit antioxidant, anti-inflammatory, bactericidal, and anti-edematous properties [22,23,24].
In a study by [25], the anti-inflammatory properties of Sambucus nigra leaf extracts were investigated. The results demonstrated that the extracts suppressed the secretion of tumor necrosis factor-alpha (TNF-α) and reduced the production of reactive oxygen species (ROS) in lipopolysaccharide (LPS)-stimulated neutrophils. These findings highlight the anti-inflammatory potential of S. nigra leaves, indicating their relevance as a botanical source for treating inflammatory skin conditions.
Berry extracts of Sambucus nigra obtained by supercritical fluid extraction exhibited promising potential for the prevention and treatment of dermatological disorders, primarily through the inhibition of collagenase and elastase—key enzymes involved in the degradation of the extracellular skin matrix. The most potent inhibitory activity was observed in the extract derived from dried berries using absolute ethanol, with collagenase inhibition reaching 84.7%, comparable to the positive control (white tea extract). Additionally, the same extract demonstrated high elastase inhibitory activity (77.3%), exceeding that of the reference compound ursolic acid. As these enzymes are critically involved in skin aging, inflammation, and loss of elasticity, the findings underscore the dermatological significance of Sambucus nigra extracts.
Moreover, these extracts exhibited antioxidant properties and were successfully encapsulated in PLGA-based polymeric nanoparticles, which improved their stability and potential skin permeability. The resulting nanostructures maintained their bioactivity and exhibited a skin-compatible pH profile, supporting their potential application in dermatological and cosmetic formulations [26].
Fruit extracts of Sambucus nigra also demonstrated strong anti-photoaging and anti-inflammatory effects in a UVB-induced human keratinocyte (HaCaT) damage model. Treatment with the extract significantly reduced ROS production, and inhibited the expression of matrix metalloproteinase-1 (MMP-1), interleukin-6 (IL-6), and vascular endothelial growth factor (VEGF), suggesting a protective effect against collagen degradation and inflammation. The underlying mechanisms included inhibition of the MAPK/AP-1 and NF-κB pathways, as well as activation of the Nrf2/HO-1 antioxidant system and the TGF-β/Smad signaling cascade responsible for type I procollagen synthesis. These results suggest that Sambucus nigra is a promising botanical agent for the prevention and treatment of photoaging and UV-induced inflammatory skin conditions [27].

3.3. Broadleaf Plantain (Plantago major)

Plantago major L., a member of the Plantaginaceae family, is a perennial herbaceous plant widely distributed across temperate and subtropical regions of Europe, Asia, and the Americas. It commonly inhabits anthropogenic environments such as roadsides, wastelands, pastures, and disturbed landscapes, reflecting its high adaptability to adverse ecological conditions [28,29,30].
The phytochemical composition of Plantago major is characterized by a wide range of biologically active compounds, including phenolic acids (notably chlorogenic and ferulic acids), iridoid glycosides (aucubin and catalpol), flavonoids (apigenin and luteolin), polysaccharides, tannins, and saponins. Recent studies have confirmed the plant’s antioxidant, anti-inflammatory, antibacterial, and wound-healing activities, which are attributed to these constituents. Of particular interest is aucubin (Figure 4), a compound with pronounced biological activity that inhibits pro-inflammatory cytokines and promotes tissue regeneration [31,32,33].
In traditional medicine across Europe and Central Asia, the leaves of Plantago major are used to treat wounds, burns, ulcers, skin irritations, as well as respiratory and digestive disorders. In Traditional Chinese Medicine (TCM), the plant is recognized for its ability to clear internal heat, promote wound healing, and reduce inflammation. Ethnobotanical studies conducted in Russia and Kazakhstan have documented the widespread use of Plantago major in the form of decoctions, infusions, and topical ointments for the treatment of various skin conditions and wounds, supporting its potential as a promising ingredient in dermatological preparations [34,35].

3.4. Canadian Goldenrod (Solidago canadensis)

Solidago canadensis is a perennial herbaceous plant belonging to the Asteraceae family, widely distributed across North America and introduced to Europe and Asia. In both traditional and official medicine, the aerial parts of the plant are used, being rich in biologically active constituents.
Solidago canadensis is characterized by a diverse phytochemical composition, including flavonoids, saponins, terpenoids, phenolic acids, essential oils, and alkaloids. The presence of these constituents underlies its investigated pharmacological activities—anti-inflammatory, antimicrobial, and diuretic effects [36,37]. In European traditional medicine, it has been used for over 700 years, particularly in the treatment of urinary tract disorders, skin inflammations, rheumatism, gout, and eczema. Contemporary studies confirm that S. canadensis extracts exhibit antibacterial, antiseptic, analgesic, diuretic, anti-inflammatory, and antioxidant effects (Figure 5). In particular, the plant’s essential oils have demonstrated activity against pathogenic fungi (Botrytis cinerea), Gram-positive bacteria, and Salmonella, as well as potent insect-repellent properties.
Flavonoids and phenolic compounds isolated from the plant show strong free radical scavenging capacity, positioning Solidago canadensis as a promising candidate for the development of phytotherapeutic and cosmetic products aimed at skin restoration, inflammation control, and prevention of age-related skin changes [38].
The leaves of Solidago canadensis are rich in a complex array of phenolic compounds, among which rutin (quercetin-3-O-rutinoside) (Figure 3) is the predominant flavonoid, known for its potent antioxidant and anti-inflammatory properties. Studies have shown that rutin and other flavonoid glycosides are capable of forming complexes with ammonium ions, resulting in novel polar compounds with notable biological activity.
These complexes exhibit stimulatory effects on root growth in soybean and chrysanthemum seedlings, particularly promoting lateral root formation, suggesting potential applications in phytotherapy and cosmetology for enhancing skin regeneration. Additionally, these compounds have been shown to induce positive chemotaxis in symbiotic bacteria such as Pseudomonas putida, indicating a microbiome-modulating effect that may enhance the skin’s defense mechanisms. At low concentrations (up to 20 µg/mL), these complexes display biostimulant activity; however, when the concentration exceeds 100 µg/mL, they begin to inhibit growth, likely due to allelopathic effects [39].

3.5. Coltsfoot (Tussilago farfara)

Tussilago farfara L., a member of the Asteraceae family, is a widely distributed perennial plant commonly found in temperate zones of Eurasia, including Europe, the Caucasus, Siberia, and the Russian Far East. According to research, in the southern regions of Primorsky Krai it predominantly grows along roadsides, in vacant lots, abandoned orchards, and other anthropogenically disturbed habitats, indicating a tendency for naturalization primarily in artificially transformed ecosystems. At the same time, the plant is actively cultivated and harvested in Bulgaria, where its raw material is used for the analysis of biologically active compounds, highlighting the persistent presence of T. farfara in both pharmaceutical practices and the regional flora [40,41].
The chemical composition of Tussilago farfara L. is notably complex and diverse, comprising flavonoids, phenolic acids, terpenoids, alkaloids, and chromones. Contemporary studies have identified over 150 compounds in the plant’s leaves, with particularly active constituents including derivatives of dicaffeoylquinic acid (e.g., compounds 7-12), which exhibit significant inhibitory activity against aldose reductase—an enzyme associated with diabetic complications [42]. Moreover, novel flavonoid glycosides have been isolated, such as kaempferol 3-O-[3,4-O-(isopropylidene)-α-l-arabinopyranoside], reported for the first time in this species. Additional constituents identified in the leaves and floral buds include sesquiterpenes, triterpenoids, chromones, chlorogenic and rosmarinic acids, as well as pyrrolizidine alkaloids, some of which are known to possess toxic properties. This extensive array of secondary metabolites underpins the pharmacological activity of the plant, including its antioxidant, anti-inflammatory, and antidiabetic effects (Figure 6) [43]. In modern formulations, these compounds may be combined with auxiliary agents such as deoxycholic acid—a secondary bile acid with surfactant and lipolytic properties—to improve transdermal delivery and efficacy in pharmaceutical and cosmetic products (Figure 7).
Tussilago farfara L. has long been utilized in both European and Asian traditional medicine for the treatment of dermatological and respiratory disorders. In Traditional Chinese Medicine, the floral buds (Farfarae flos) are primarily used due to their expectorant, anti-inflammatory, and soothing properties, which also extend to the treatment of skin irritations, wounds, and acne. Phytochemical studies have confirmed that the major bioactive compounds in the plant include flavonoids, phenolic acids, and sesquiterpenes—particularly tussilagone—which exhibit antioxidant, antimicrobial, and wound-healing activities. In Ayurvedic practice, the plant is also used topically for inflammatory skin conditions and to promote tissue regeneration. Recent studies suggest that T. farfara demonstrates significant anti-inflammatory effects by suppressing the expression of pro-inflammatory cytokines and inhibiting key enzymes involved in skin inflammation [44,45].
In Belarusian folk medicine, Tussilago farfara L. has been widely employed topically for skin inflammations, headaches, and wound treatment. Ethnobotanical fieldwork conducted in the Lyuban district documented the use of leaves and flowers in the form of infusions, decoctions, and fresh applications for treating wounds and inflamed skin. Local residents applied compresses of fresh leaves directly to affected areas and also used infusions both internally and externally to accelerate healing and relieve pain. These findings highlight the enduring use of T. farfara in Eastern European ethnomedicine as an accessible and effective remedy for inflammatory skin conditions, supporting its potential inclusion in dermatological phytopharmaceuticals [46].

3.6. Common Blackberry (Rubus vulgaris)

Rubus vulgaris Weihe & Nees, a member of the Rosaceae family, is a perennial shrub widely distributed across temperate regions of Europe, Asia, and North America. The plant typically grows along forest edges, in shrublands, along roadsides, and in disturbed habitats, demonstrating a high degree of adaptability to diverse ecological conditions. In Kazakhstan, Rubus vulgaris is commonly found in foothill and forest-steppe zones [47,48,49,50].
The phytochemical profile of R. vulgaris includes a wide array of bioactive compounds such as flavonoids (quercetin, kaempferol), anthocyanins (cyanidin, delphinidin), phenolic acids (gallic and ellagic) (Figure 8), tannins, triterpenes, and vitamins (C, E, and K). Of particular interest is the high content of ellagitannins and anthocyanins, which possess strong antioxidant and anti-inflammatory properties (Figure 9). Recent studies have shown that R. vulgaris extracts exhibit antimicrobial, anticancer, and wound-healing activities, primarily attributed to the presence of these compounds. For example, anthocyanins contribute to the neutralization of free radicals, thereby reducing oxidative stress and inflammatory responses in tissues [51,52,53,54].
In traditional medicine across Europe and Asia, the leaves and roots of blackberry (Rubus vulgaris) have been used to treat diarrhea, oral inflammations, skin disorders, and wounds. Decoctions and infusions were commonly applied as astringent and anti-inflammatory remedies for gastrointestinal and dermatological conditions. Ethnobotanical studies conducted in various regions confirm the widespread use of Rubus vulgaris in folk medicine for the treatment of skin diseases, highlighting its potential application in modern dermatological practice [55,56].

3.7. Common Dandelion (Taraxacum officinale)

Taraxacum officinale, a member of the Asteraceae family, is a widely distributed perennial herbaceous plant found across various climatic zones of Europe, Asia, North America, and Central Asia. In the territories of Kazakhstan, Russia, and Uzbekistan, dandelion commonly grows in meadows, along roadsides, in pastures, and urban areas, demonstrating high ecological adaptability and capacity for vegetative reproduction [56,57]. Due to its ease of collection and resilience to anthropogenic impacts, T. officinale is actively employed in both traditional and official phytotherapy.
The phytochemical composition of Taraxacum officinale is rich in bioactive compounds, including triterpenoids (taraxerol, taraxasterol) (Figure 10), flavonoids (luteolin, apigenin), phenolic acids (chlorogenic, caffeic, p-coumaric), inulin, bitter sesquiterpene lactones, as well as vitamins A, C, and E [58,59]. Of particular interest are hydroxycinnamic acids such as chlorogenic and cynarin, which exhibit pronounced antioxidant activity. The plant also contains saponins and mucilaginous substances that contribute to its emollient and anti-inflammatory effects. The antibacterial properties of T. officinale extracts are attributed to the synergistic action of flavonoids and phenolic acids, which inhibit the growth of pathogenic microorganisms, including Staphylococcus aureus and Escherichia coli [60,61].
In traditional medicine systems of Europe, China, and Central Asia, the leaves, roots, and latex of Taraxacum officinale have long been used for the treatment of dermatological conditions, including eczema, furunculosis, acne, and inflammatory skin eruptions. In Tibetan and Uyghur medicine, the root of the plant is valued for its cooling, detoxifying, and wound-healing properties. In Ayurveda, T. officinale is considered a pitta-reducing herb, believed to purify both the skin and blood. Recent pharmacological studies confirm that dandelion extracts are capable of suppressing pro-inflammatory markers (TNF-α, IL-6), enhancing antioxidant enzymes (SOD, CAT), and promoting skin regeneration [62,63].
Ethnobotanical surveys conducted in the southern regions of Kazakhstan and Kyrgyzstan have documented the use of fresh juice or compresses made from crushed T. officinale leaves for the treatment of wounds, inflammations, and insect bites. In certain localities, the plant is also applied in the form of ointments and infusions for topical use in skin disorders. These practices highlight a longstanding folk tradition of employing dandelion as an accessible remedy for inflammatory and infectious skin conditions, underscoring its potential as a valuable component in dermatological phytotherapeutics [64].

3.8. Common Flax (Linum usitatissimum)

Linum usitatissimum is one of the oldest cultivated crops, historically grown for both its fiber and oil. The plant exhibits high adaptability to a range of climatic conditions, which has facilitated its cultivation in more than 60 countries worldwide, including Canada, China, India, the United States, and most European nations. The most productive regions for flax cultivation are the Canadian Prairies (Manitoba, Saskatchewan, Alberta) and central India, where it is primarily grown as an oilseed crop. In Europe, flax is traditionally cultivated for fiber production, particularly in northwestern regions such as France, Belgium, and the Netherlands. The taxonomy of flax includes various forms—fiber flax, intermediate, and oilseed types—that differ morphologically and agronomically. All cultivated forms are believed to originate from the wild species Linum angustifolium (syn. L. bienne), domesticated independently in multiple regions since the Neolithic era. Due to its ecological plasticity, flax has successfully adapted to both temperate and warm climates. Its seeds and oil are widely utilized in food, pharmaceutical, and industrial applications [65,66].
Linum usitatissimum seeds (commonly known as flaxseed) possess a rich chemical profile, comprising proteins, lipids, dietary fibers, minerals, and biologically active compounds. Studies have shown that partial defatting and roasting of flaxseeds significantly increase the levels of crude protein, ash, and essential minerals such as potassium, magnesium, and iron, while enhancing functional properties like foaming capacity and water absorption [67]. Additionally, flaxseeds contain a substantial quantity of phenolic compounds, including lignans (notably secoisolariciresinol diglucoside, as shown in Figure 11), tannins, and flavonoids, which exhibit antibacterial activity against Gram-negative bacteria such as Escherichia coli and Salmonella typhimurium [68]. Germination of flaxseeds leads to a decrease in oil content and an increase in ascorbic acid and carotenoid levels; however, it also results in a reduction of total phenolic acids and oil stability, potentially affecting antioxidant capacity [69]. These characteristics underscore the value of Linum usitatissimum as a raw material in the food, pharmaceutical, and cosmetic industries.
Linum usitatissimum (flaxseed) has been widely used in traditional medicine for the treatment of skin disorders due to its anti-inflammatory, antioxidant, and regenerative properties. Studies have demonstrated that topical application of 5% and 10% flaxseed-based gel significantly accelerates the healing of full-thickness skin wounds in rats by promoting collagen synthesis, fibroblast proliferation, and vascularization [6]. Moreover, in horses exhibiting hypersensitivity to Culicoides bites, dietary supplementation with flaxseed reduced the affected skin area and lowered the levels of long-chain saturated fatty acids in hair, indicating an anti-inflammatory effect [70]. In Turkish folk medicine, flaxseed is traditionally employed in the form of decoctions, ointments, and poultices to treat burns, eczema, hemorrhoids, and other skin conditions, as well as to facilitate the maturation of purulent wounds [71]. These findings support the therapeutic potential of Linum usitatissimum in dermatological applications, although further clinical research is necessary to optimize its use.

3.9. European Cranberrybush (Viburnum opulus)

Viburnum opulus is a perennial shrub belonging to the family Adoxaceae, widely distributed across Europe, North Africa, and Asia. In both traditional and official medicine, various parts of the plant—including the bark, fruits, and flowers—are used due to their rich chemical composition and diverse pharmacological properties [72,73].
The bark of V. opulus contains tannins, triterpenoid saponins, organic acids, and flavonoids. The fruits are rich in vitamins C and K, carotenoids, organic acids, and pectins. This composition contributes to the plant’s broad therapeutic effects, including spasmolytic, hypotensive, hypolipidemic, diuretic, anti-inflammatory, and sedative activities (Figure 12) [74,75,76].
Viburnum opulus L. exhibits high potential for dermatological applications, owing to the wide array of bioactive compounds found in its various morphological parts. According to a review by Kajszczak et al. [77], the fruits, bark, and leaves of V. opulus are rich in phenolic compounds, including flavonols (rutin, isorhamnetin), anthocyanins (cyanidin-3-glucoside) (Figure 13), catechins, and procyanidins. These constituents are responsible for the plant’s antioxidant, anti-inflammatory, and cytoprotective properties, which are particularly relevant in the treatment of inflammatory and age-related skin conditions.
Viburnum opulus extracts have been shown to effectively inhibit inflammatory responses mediated by reactive oxygen species and proinflammatory cytokines. A study by Moldovan et al. [78] demonstrated that silver nanoparticles synthesized using V. opulus fruit extract exhibit significant anti-inflammatory activity both in vitro (in UV-irradiated HaCaT keratinocyte cultures) and in vivo (in an acute inflammation model in rats). These findings suggest the potential use of V. opulus-derived compounds in topical formulations for the treatment of dermatological inflammation, including sunburn, eczema, and dermatitis.
A pharmacological study conducted by Khvorost et al. [79] further confirmed the suitability of V. opulus fruits for application in the cosmetic industry. Extracts obtained from the fruits exhibit antiseptic, moisturizing, whitening, and astringent properties, making them suitable for inclusion in masks, toners, creams, and soaps. Additionally, the phenolic constituents of V. opulus have been shown to promote skin regeneration and reduce oxidative stress induced by ultraviolet radiation. The study also noted that aqueous and ethanolic extracts contribute to improved skin condition by inhibiting matrix-degrading enzymes such as matrix metalloproteinase-1 (MMP-1) and reducing the production of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α).

3.10. Garden Angelica (Angelica archangelica)

Angelica archangelica, also known as garden angelica, is a perennial herbaceous plant belonging to the family Apiaceae. It has been traditionally used in both European and Eastern medicine and is widely distributed across the northern and temperate regions of Europe and Asia. In medicine and cosmetology, the primary parts used are the roots and rhizomes, which possess a broad range of pharmacological properties due to their complex chemical composition [80,81].
The rhizomes of A. archangelica contain essential oils rich in furanocoumarins, sesquiterpene lactones, organic acids, tannins, and flavonoids. These compounds confer antibacterial, anti-inflammatory, spasmolytic, and antiseptic properties to the plant. Studies have demonstrated that angelica extracts can inhibit inflammatory processes by suppressing key pro-inflammatory mediators such as interleukin-1β and tumor necrosis factor-alpha (TNF-α). In addition, furanocoumarins exhibit photosensitizing activity, which is therapeutically applied in dermatology for the treatment of psoriasis and vitiligo within the framework of PUVA (psoralen + UVA) therapy [82,83,84,85].
Angelica archangelica also exhibits high antioxidant potential, making it a promising ingredient in skincare formulations aimed at protecting the skin from oxidative stress and premature aging. Extracts from the leaves and stems have demonstrated significant inhibition of lipid peroxidation (up to 93.9%) and strong free radical scavenging activity (DPPH, ABTS, DMPD), comparable to standard antioxidants such as α-tocopherol and Trolox. Furthermore, the extracts are rich in phenolic and flavonoid compounds known for their protective and membrane-stabilizing effects on skin cells. The mineral composition of the plant—including magnesium, calcium, phosphorus, and zinc—also contributes to the reinforcement of the skin barrier, regulation of inflammatory responses, and stimulation of tissue regeneration. The combined action of antioxidants and minerals makes Angelica archangelica a valuable botanical resource for the development of natural products intended for aging, sensitive, and damaged skin [86,87].
Plant extracts, particularly root essential oils, have been shown to suppress the expression of pro-inflammatory cytokines (e.g., interleukin-6), the activity of the NF-κB transcription factor, and the generation of reactive oxygen species (ROS), thereby protecting the skin from oxidative and inflammatory damage. In addition, the essential oils of Angelica archangelica have demonstrated the ability to enhance skin permeability to active compounds, highlighting their potential use in transdermal drug delivery systems. Imperatorin, a key furanocoumarin (Figure 14) component of A. archangelica essential oil, plays a central role in these effects (Figure 15).
Due to these properties, components of Angelica archangelica are increasingly incorporated into creams, serums, lotions, and other cosmetic formulations aimed at skin restoration, protection, and rejuvenation [88].

3.11. Greater Burdock (Arctium lappa)

Arctium lappa L., a member of the Asteraceae family, is a widely distributed biennial plant native to Europe, Asia, and North America. It typically grows in temperate climates and is commonly found along roadsides and in wastelands, abandoned gardens, and other disturbed habitats. The plant is cultivated in East Asia (notably China and Japan) and several European countries for both medicinal and nutritional purposes [89,90,91].
The phytochemical profile of Arctium lappa includes polyphenolic compounds, lignans (arctiin and arctigenin) (Figure 16), inulin, sesquiterpene lactones, phenolic acids (such as chlorogenic and caffeic acids), and essential oils. Recent studies highlight the pharmacological relevance of arctigenin and its derivatives, which exhibit significant antioxidant, anti-inflammatory, and anticancer properties. Lignans derived from burdock have demonstrated the ability to inhibit pro-inflammatory cytokine production and exert protective effects on skin cells [92,93,94].
In folk medicine, Arctium lappa is widely recognized as an effective remedy for inflammatory skin conditions such as dermatitis, eczema, and acne, as well as for burns, purulent lesions, and metabolic disorders. In Traditional Chinese and Japanese Medicine, burdock root is used for its detoxifying, anti-inflammatory, and wound-healing properties. Ethnobotanical studies from Eastern Europe also document the traditional use of A. lappa in the form of ointments, infusions, and compresses for the treatment of skin inflammation, wounds, and acne. Its pronounced biological activity highlights the potential of burdock for applications in dermatology and cosmetology [95,96].

3.12. Inula helenium L.

Inula helenium L., commonly known as elecampane, is a perennial herbaceous plant from the Asteraceae family, predominantly found in the temperate zones of Europe and Asia. In the wild, it is widespread across Eastern and Central Europe, the Caucasus, Western Siberia, Central Asia, and China. In Russia, I. helenium is broadly distributed in the European part, particularly in forested and forest-steppe regions, as well as in the Urals and southern Siberia. The plant favors moist soils rich in organic matter and typically grows along forest edges, riverbanks, wet meadows, and near marshes. While it tolerates partial shade, it thrives best in open, sunlit areas. Due to its recognized medicinal properties, Inula helenium is also cultivated in various regions as a valuable medicinal crop [97,98].
The primary medicinal parts of the plant are its roots and rhizomes, which are rich in a complex array of biologically active compounds, making the species a promising candidate for dermatological applications, particularly in the treatment of inflammatory and infectious skin conditions [99].
The root of I. helenium contains a high concentration of inulin (Figure 17)—a naturally occurring polysaccharide from the fructan group—which represents a significant portion of the plant’s carbohydrate reserves [100]. Inulin not only enhances the plant’s nutritional value but also exhibits notable prebiotic activity, contributing to the maintenance of the skin and mucosal microbiota. Additionally, literature reports indicate that inulin may strengthen skin barrier functions and exert anti-inflammatory effects, thereby positioning it as a promising component in the development of formulations for sensitive and damaged skin. The presence of inulin in combination with other bioactive constituents of I. helenium, such as sesquiterpene lactones and essential oils, further enhances its dermatological value [101].
Flavonoids and phenolic acids present in Inula helenium—including quercitrin, isoquercitrin, ferulic acid, and caffeic acid—contribute to the stabilization of cell membranes, enhancement of microcirculation, and protection of tissues against oxidative stress. These compounds exhibit antioxidant activity, inhibit lipid peroxidation, and protect epidermal cells from damage induced by ultraviolet radiation and reactive oxygen species [102,103].
Topical application of Inula helenium-based preparations has been shown to reduce skin swelling, erythema, and itching, making them beneficial in the treatment of eczema, dermatitis, psoriasis, and allergic skin eruptions. Furthermore, I. helenium extracts have been reported to accelerate reparative processes by stimulating fibroblast proliferation and collagen synthesis, thus positioning the plant as a valuable ingredient in wound-healing ointments and creams, particularly for chronic ulcers, burns, and abrasions [104].
In cosmetic practice, Inula helenium is incorporated into cleansing and toning formulations for skin prone to inflammation, irritation, and breakouts. Infusions and extracts are used in lotions, masks, and creams that help even skin tone, reduce oiliness, cleanse pores, and alleviate microinflammation. Decoctions of I. helenium are also applied in scalp care to strengthen hair, relieve itching, and reduce dandruff [105].

3.13. Marshmallow (Althaea officinalis)

Althaea officinalis is a perennial herbaceous plant native to temperate regions of Europe, Western Asia, and North Africa. It typically grows in moist meadows, along riverbanks and lake shores, as well as in marshy lowlands [106].
The main biologically active constituents of A. officinalis include polysaccharides (mucilage), flavonoids, tannins, and pectins (Figure 18) [107]. The mucilage found in the roots of the plant, primarily composed of galacturonic acid (Figure 19)—the principal structural unit of mucilaginous polysaccharides—exhibits demulcent and emollient properties, making it effective in the treatment of inflammatory skin conditions [108]. Flavonoids and tannins contribute to its anti-inflammatory and antimicrobial activities, promoting wound healing and reducing skin irritation [109].
In dermatology, Althaea officinalis is used to treat various skin conditions, including eczema, dermatitis, and psoriasis [110]. Herbal preparations derived from marshmallow help reduce inflammation, accelerate tissue regeneration, and protect damaged skin from external irritants. Infusions and decoctions of marshmallow root are traditionally applied as compresses and poultices to relieve symptoms of dermatological disorders [111].
Pharmacological studies support the efficacy of A. officinalis in the treatment of skin diseases. The mucilage’s demulcent properties form a protective barrier on the skin surface, preventing dehydration and promoting wound healing. The anti-inflammatory activity of flavonoids and tannins helps alleviate inflammation and prevents secondary infections in damaged skin areas [112,113].

3.14. Narrow-leaved Lavender (Lavandula angustifolia)

Lavandula angustifolia is a perennial subshrub from the Lamiaceae family, naturally occurring in mountainous regions of the Mediterranean, ranging from Spain and France to Italy, primarily at altitudes above 1500 m above sea level [114]. Two main subspecies are widely recognized: ssp. angustifolia, native to the French and Italian Alps, and ssp. pyrenaica from the Pyrenees. The latter has been shown to possess a different essential oil composition and is considered less suitable for commercial use. Due to its high ecological plasticity and resistance to adverse environmental conditions, L. angustifolia is successfully cultivated in Europe, Asia, and North America, particularly in countries with temperate climates and well-drained soils [115].
The essential oil of Lavandula angustifolia is characterized by a complex and diverse chemical composition, including mono- and sesquiterpenoids, oxygenated compounds, and mineral elements. According to Jianu et al. [116], the primary constituents of the essential oil extracted from lavender flowers are caryophyllene (24.12%), β-phellandrene (16%), and eucalyptol (15.69%). Additionally, terpinen-4-ol (9.57%), α-terpineol (6%), and borneol (5.07%) were identified, indicating a high concentration of oxygenated monoterpenes (Figure 20). Another study reports that the composition of lavender essential oil may vary significantly depending on cultivation conditions and varietal differences [117]. Beyond terpenoids, the aerial parts of L. angustifolia have been found to contain compounds such as herniarin and coumarins, as well as a broad range of macro- and microelements, including Ca, Mg, Zn, Mn, Fe, Cu, and Na, further enriching the plant’s biochemical profile [118].
Lavandula angustifolia has long been used in traditional medicine due to its pronounced pharmacological properties. Extracts and essential oil derived from the plant are applied in the treatment of inflammatory and infectious skin diseases, as well as in the management of burns, wounds, acne, and eczema. According to Cardia et al. [119], the essential oil of L. angustifolia exhibits notable anti-inflammatory effects in both topical and systemic applications. In experimental animal models, the oil was shown to reduce edema, myeloperoxidase (MPO) activity, and nitric oxide (NO) production, indicating its ability to suppress acute inflammatory responses. Furthermore, as reported by Sharma et al. [120], lavender oil demonstrates antiseptic, antibacterial, and antifungal activities, making it effective against skin infections, including resistant strains such as Staphylococcus aureus. The plant also promotes tissue regeneration and wound healing. It is widely utilized in the form of creams, ointments, infusions, and essential oil preparations, including aromatherapy, as an adjunct treatment for dermatological and psychosomatic conditions.
In cosmetology and dermatology, the essential oil of Lavandula angustifolia is actively employed for its anti-inflammatory, antibacterial, and antioxidant properties. Recent studies confirm its efficacy as a safe and natural skincare agent, particularly in depigmentation therapies. For instance, a study by Andrei et al. [121] demonstrated that a lavender-based cream reduced melanin levels in hyperpigmented skin areas by over one-third after two months of application. The key active compound, terpinen-4-ol (Figure 21), was identified as a potent tyrosinase inhibitor of the principal enzyme involved in melanogenesis—highlighting lavender oil as a promising natural depigmenting agent [121].
Additionally, as highlighted by Galea et al. [122], lavender ranks among the most sought-after essential oils in the dermo-cosmetic industry due to its soothing effects on irritated skin, along with its notable antibacterial and antiseptic properties. These attributes make it particularly valuable in skincare formulations for problematic skin, including acne, irritation, and inflammatory conditions.
It is also important to note that Lavandula angustifolia not only exerts beneficial effects on the skin but also promotes tissue regeneration and exhibits wound-healing properties, making it suitable for the treatment of burns and cutaneous infections. The study by Sharma et al. [120] emphasizes that lavender oil penetrates the skin rapidly, improves conditions such as eczema, psoriasis, and acne, and may also help prevent the formation of scar tissue. Thus, lavender occupies a prominent place among botanical ingredients in cosmetic formulations, owing to its comprehensive therapeutic profile.

3.15. Red Clover (Trifolium pratense L.)

Trifolium pratense L., commonly known as red clover, is a perennial herbaceous plant belonging to the Fabaceae family. It is widely distributed across temperate and subtropical regions of both hemispheres. In both wild and cultivated forms, it occurs in North America, Europe, northern China and Japan, southern Latin America, and Australasia, typically thriving in well-drained soils with neutral to slightly acidic pH (optimal range: 6.0–7.6) and moderate climates with annual precipitation exceeding 550 mm [123]. Historically, the plant has been cultivated in Europe since the 3rd century AD, and its widespread adoption in crop rotation during the 16th–17th centuries significantly contributed to agricultural development, particularly due to its nitrogen-fixing capacity. Today, T. pratense is actively grown in both organic and conventional farming systems worldwide, including in Russia, Japan, Canada, the United States, Brazil, and Australia [124].
Red clover is a valuable medicinal plant extensively used in phytotherapy and cosmetology due to its rich chemical composition and well-documented pharmacological properties. The main bioactive constituents of T. pratense extracts include isoflavones (genistein, daidzein, biochanin A (Figure 22), formononetin), phenolic acids, flavonoids, tannins, and polysaccharides (Figure 23). Isoflavones from red clover exhibit estrogen-like activity, making this plant particularly relevant for skincare formulations targeting aging skin affected by hormone-related changes, including decreased elasticity, dryness, and increased sensitivity [125,126].
In dermatology, Trifolium pratense (red clover) extracts have demonstrated notable efficacy as anti-inflammatory and wound-healing agents. A study by Farahpour et al. [127] revealed that topical application of a hydroethanolic extract of T. pratense on wounds in laboratory animals significantly accelerated the healing process. This was accompanied by active fibroblast proliferation, stimulation of collagen synthesis and re-epithelialization, as well as downregulation of pro-inflammatory and apoptotic markers. These findings highlight the therapeutic potential of red clover in the treatment of wounds, burns, and chronic dermatoses.
Additional value lies in combined phytotherapeutic formulations based on T. pratense and other medicinal plants. For instance, Antonescu et al. [128] developed topical preparations combining red clover and basil (Ocimum basilicum) extracts, which exhibited strong antioxidant, antibacterial, and anti-inflammatory activities. These compositions proved effective in restoring the skin barrier and promoting tissue regeneration, suggesting their potential use in managing inflammatory skin conditions such as acne and eczema.
In cosmetic applications, T. pratense is regarded as a promising anti-aging ingredient, particularly for postmenopausal women. Its isoflavones, acting as phytoestrogens, contribute to maintaining dermal structure and reducing the appearance of wrinkles. Furthermore, the plant’s phenolic compounds provide antioxidant protection to skin cells against damage induced by ultraviolet radiation and environmental stressors [129].
Due to its rich phytochemical composition and multifunctional properties, Trifolium pratense can be incorporated into a wide range of dermatological and cosmetic formulations, including creams, gels, masks, therapeutic ointments, and anti-aging products. Contemporary research supports its safety, biocompatibility, and high efficacy in topical applications.

3.16. Virginian Witch Hazel (Hamamelis virginiana)

Hamamelis virginiana is a deciduous shrub belonging to the family Hamamelidaceae, native to the eastern regions of North America. Its leaves and bark are widely utilized in medicine and cosmetology due to their rich content of biologically active compounds [130,131].
The leaves of H. virginiana contain significant levels of tannins (particularly hamamelitannin), flavonoids (including quercetin), gallic acid (Figure 24), and polysaccharides. The bark is especially rich in hydrolyzable tannins. This phytochemical composition underlies the plant’s astringent, anti-inflammatory, and antioxidant properties [132,133].
In dermatology, Hamamelis virginiana extract is used for the care of oily and problematic skin: it regulates sebum production, tightens pores, and helps prevent inflammation. Its anti-inflammatory properties reduce redness and irritation, making it particularly beneficial for sensitive skin. Moreover, witch hazel strengthens capillary walls, thereby diminishing the appearance of couperose (telangiectasia) [134,135].
In cosmetology, H. virginiana is incorporated into toners, creams, and cleansing formulations designed for problem skin, where it aids in reducing sebum secretion and minimizing pore size. Its vascular-strengthening effects are utilized in products aimed at treating couperose. In men’s skincare, witch hazel is commonly included in aftershave products for its soothing and restorative effects on the skin [136,137].

3.17. Smooth Brome (Bromus inermis Leyss.)

Bromus inermis Leyss. is a rhizomatous perennial grass belonging to the Poaceae family, native to Central and Eastern Europe and Western Asia. It has been widely naturalized in North America, Canada, Australia, and several Eastern European countries. Due to its adaptability to diverse climatic conditions and high drought resistance, Bromus inermis is extensively cultivated in temperate regions and thrives in steppe, meadow, and subalpine zones. It is commonly employed as a forage crop, a soil-stabilizing species, and a component in land reclamation efforts [138,139].
The phytochemical composition of Bromus inermis underpins its potential pharmacological activity. Analyses of aqueous and ethanolic extracts have revealed the presence of phenolic compounds (including phenolic acids and flavonoids), coumarins, essential oils, and structural polysaccharides derived from the plant cell wall [140]. Of particular interest is the detection of chlorogenic (Figure 25) and ferulic acids in the leaves and stems—bioactive molecules with well-established antioxidant and anti-inflammatory properties. These compounds have been shown to neutralize reactive oxygen species (ROS) and downregulate the expression of pro-inflammatory cytokines, which is of therapeutic relevance in treating dermatological conditions associated with oxidative stress and chronic inflammation.
Due to the demonstrated antibacterial and antifungal properties of Bromus inermis extracts, the plant is considered a potential source of bioactive compounds for dermatological and cosmetic applications. Studies have shown inhibition of pathogenic strains including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans, suggesting the possible incorporation of this species into topical formulations for the treatment of acne, seborrheic dermatitis, mycoses, and other infectious-inflammatory skin conditions [141].
Beyond its antimicrobial effects, Bromus inermis extracts exhibit regenerative and moisturizing potential, attributed to the presence of polysaccharides and humic-like substances. These properties support the use of the plant as a base for phytocosmetic compositions with restorative action, particularly for damaged epidermis, aging skin, and increased sensitivity. Additionally, the plant’s low allergenic potential makes it suitable for inclusion in hypoallergenic dermatological products. In veterinary medicine, Bromus inermis has also been explored as a therapeutic component in managing atopic skin conditions in animals caused by seasonal airborne allergens [142], further confirming its versatility and safety profile.

3.18. Turmeric (Curcuma longa)

Curcuma longa is a perennial herbaceous plant belonging to the family Zingiberaceae. It is native to the southwestern region of India, from where it has spread to various parts of Asia, Africa, and South America. Today, turmeric is cultivated across a broad geographic range, including India, China, Indonesia, Thailand, Sri Lanka, Bangladesh, and tropical regions of Africa and South America. India remains the world’s largest producer and exporter of turmeric [143,144]. Experimental studies have also demonstrated the successful cultivation of Curcuma longa in a variety of soil types, including dark-red, gray, and red soils in Okinawa (Japan), indicating the species’ strong adaptability to diverse agroecological conditions [145].
The chemical composition of Curcuma longa is highly diverse and comprises more than 235 identified compounds, the majority of which are phenolic and terpenoid metabolites. The principal bioactive constituents responsible for its pharmacological effects are curcuminoids (diarylheptanoids) and essential oils. Curcumin (C21H20O6) (Figure 26), demethoxycurcumin, and bisdemethoxycurcumin—the three primary curcuminoids found mainly in the rhizomes—constitute approximately 3–15% of the dry weight and exhibit well-documented anti-inflammatory, antioxidant, and anticancer activities [145]. The essential oil fraction, composed mainly of sesquiterpenoids and monoterpenes, varies in composition depending on geographical origin, cultivar, and cultivation conditions [146]. Notable constituents include ar-turmerone, α-turmerone, and β-turmerone, which serve as marker compounds for quality assessment and standardization of Curcuma longa-based products [147]. Additionally, GC-MS analysis of C. longa leaf essential oil revealed the presence of α-phellandrene, eucalyptol, and 2-carene, all of which possess antioxidant and antibacterial activities [148,149].
Curcuma longa has long held a significant position in traditional Asian medicine. It has been extensively used in Ayurvedic, Siddha, Chinese, and Tibetan systems for the treatment of various skin ailments, including wounds, burns, and infections, and as a cosmetic agent to improve complexion and skin health. Historically, turmeric rhizome powder was applied topically for skin purification, acne treatment, and inflammation reduction, as well as in the form of pastes and creams to combat photoaging and skin irritation [150,151].
Modern research validates these traditional applications and further elucidates the dermatological potential of Curcuma longa. For instance, it has been demonstrated that a hot-water extract of Curcuma longa (WEC) significantly suppresses inflammatory responses in UVB-irradiated human keratinocytes. The extract reduces the production of pro-inflammatory cytokines such as TNF-α and modulates the synthesis of hyaluronic acid, thereby improving skin hydration and barrier function. These findings support the systemic application of C. longa in skin protection and restoration [152].
Additionally, topical formulations of turmeric extract have been developed using liposomes, ethosomes, and transfersomes, which have shown enhanced hydration effects and seboregulation with prolonged use. These advanced delivery systems also provide photoprotective, antioxidant, and moisturizing benefits, establishing Curcuma longa as a promising ingredient for anti-aging and therapeutic cosmeceuticals [153].

3.19. White Willow (Salix alba)

Salix alba, commonly known as white willow, is a widely distributed deciduous tree species from the Salicaceae family, predominantly found in temperate regions. Its natural range spans across Europe, Western and Central Asia, and parts of North Africa. In the wild, S. alba typically grows along rivers and on lake shores, wet meadows, floodplains, and other moist habitats. It thrives particularly well in riparian zones, where it plays a crucial ecological role in bank stabilization and ecosystem support [154,155].
Salix alba L. is characterized by a rich chemical profile, comprising over 300 identified secondary metabolites, including phenolic glycosides (notably salicin), flavonoids (e.g., quercetin, rutin, catechins), organic acids, lignans, terpenoids, and simple phenolics. The primary bioactive compound—salicin (Figure 27)—is metabolized in the human body into salicylic acid, which exhibits pronounced anti-inflammatory and analgesic properties similar to those of aspirin. Studies have demonstrated that S. alba bark extract possesses not only strong antioxidant activity but also significant antimicrobial properties, including the inhibition of pathogenic bacteria such as Escherichia coli and Staphylococcus aureus, as well as fungi. This makes the plant a promising candidate for the development of topical formulations for the treatment of inflammatory and infectious skin diseases.
In addition, the phenolic compounds and flavonoids of S. alba have been shown to suppress the activity of pro-inflammatory cytokines (TNF-α, IL-6) and enzymes (COX-1, COX-2) involved in inflammatory pathways. These effects suggest its potential application in both dermatology and cosmetology, particularly in the treatment of acne, dermatitis, eczema, and photoaging of the skin [156,157,158].
The studies by L.M. Maloshtan and V.V. Pidgaina (2022) [159], as well as that of Edson L. Maistro et al. (2020) [160], demonstrated that Salix alba L. (white willow) holds significant potential for the treatment of dermatological conditions, particularly those of inflammatory and allergic origin. In preclinical investigations of a topical cream containing S. alba bark extract and zinc, conducted in a model of allergic contact dermatitis, a statistically significant reduction in IgE levels and neutrophil phagocytic activity was observed, indicating pronounced immunotropic effects. The cream showed efficacy comparable to or exceeding that of reference drugs, supporting its potential use in the comprehensive treatment of inflammatory and allergic skin conditions associated with pruritus, erythema, and impaired barrier function.
Additionally, Maistro et al. [160] reported that Salix alba bark extract—rich in phenolic constituents such as salicin, salicylic acid, salidroside, saligenin, and salicortin—exhibits potent antioxidant and anti-inflammatory activity. These compounds act synergistically to suppress inflammation mediated by proinflammatory cytokines. Although moderate genotoxic effects were observed at high concentrations in leukocyte cultures, such effects were absent in metabolically active systems (HepG2), confirming the relative safety of topical use. Therefore, Salix alba can be considered a promising botanical source for the development of topical preparations aimed at controlling inflammation, modulating cutaneous immune responses, and preventing the chronic progression of dermatoses.

3.20. White Wormwood (Artemisia terrae-albae)

Artemisia terrae-albae Krasch., a member of the Asteraceae family, is a perennial subshrub widely distributed across arid regions of Central Asia and Southern Europe. This plant thrives in dry steppe, semi-desert, and desert habitats characterized by poor soils and low moisture availability, reflecting its remarkable adaptability and resistance to extreme environmental conditions [161,162,163].
The chemical composition of A. terrae-albae includes a wide range of biologically active constituents, most notably terpenoids (mono- and sesquiterpenes), flavonoids (such as kaempferol, quercetin, and luteolin), phenolic acids (including chlorogenic, caffeic, and gallic acids), coumarins, and essential oils. Recent studies have demonstrated the plant’s antioxidant, anti-inflammatory, antibacterial, antifungal, and wound-healing properties, which are attributed to these bioactive compounds. Sesquiterpene lactones—such as artabsin (Figure 28) and tauremizine—exhibit particularly potent biological activity, effectively suppressing inflammatory responses and promoting the regeneration of damaged tissues [164,165,166].
In traditional medicine of Central Asia and Eastern Europe, Artemisia terrae-albae is used to treat skin disorders such as dermatitis, eczema, and psoriasis, as well as inflammatory conditions, wounds, and burns. In Traditional Chinese Medicine, various Artemisia species are recognized for their applications in treating inflammation and bacterial and fungal infections, and are commonly included in medicinal baths and topical ointments. Ethnobotanical studies conducted in Kazakhstan and Uzbekistan confirm the widespread use of A. terrae-albae in the form of decoctions, infusions, and topical extracts, highlighting its potential for the development of modern pharmaceutical formulations with pronounced antibacterial and anti-inflammatory properties [167,168,169].

4. Perspectives for Investigations

The medicinal plants examined in this study present substantial potential for integration into therapeutic applications targeting various dermatological conditions (Table 1). Detailed phytochemical analysis emphasizes the presence of bioactive constituents, notably flavonoids, anthocyanins, phenolic acids, tannins, sesquiterpenes, and polysaccharides, each recognized for their potent antioxidant, anti-inflammatory, antimicrobial, and wound-healing properties. Such pharmacological actions substantiate traditional ethnomedicinal practices, supporting their efficacy and relevance in modern dermatological formulations.
The comprehensive assessment covers species including Rubus vulgaris, Plantago major, Artemisia terrae-albae, Eryngium planum, Angelica archangelica, Bergenia crassifolia, Arctium lappa, Hamamelis virginiana, Inula helenium, Linum usitatissimum, among others, traditionally utilized in managing dermatological disorders like eczema, psoriasis, acne, and dermatitis. The contemporary scientific literature confirms the therapeutic value of these plants, elucidating mechanisms involving modulation of pro-inflammatory cytokine production, inhibition of inflammatory enzymes (such as COX-2), and enhancement of skin regeneration and barrier repair processes.
For instance, Plantago major contains aucubin, a bioactive iridoid glycoside renowned for its pronounced anti-inflammatory and regenerative capabilities. Similarly, Rubus vulgaris is notable for its high content of anthocyanins and ellagitannins, compounds that confer significant antioxidant and antimicrobial effects. Artemisia terrae-albae, rich in sesquiterpenes such as chamazulene, demonstrates substantial wound-healing and anti-inflammatory activities.
Integration of these medicinal plants into dermatological and cosmeceutical products offers an effective and safer alternative to synthetic therapeutics, which often present adverse effects upon prolonged use. However, several challenges remain to be addressed to ensure their clinical applicability. These include the need for standardization of active constituents, control of batch-to-batch variability, and establishment of pharmacokinetic and toxicological profiles. Despite the long history of use, rigorous clinical trials are still lacking for most plant-based dermatological agents, limiting their evidence-based validation. Furthermore, the complex regulatory landscape in different countries hinders the formal approval of herbal preparations, requiring harmonized guidelines on quality, safety, and efficacy.
To facilitate broader clinical acceptance, future research should focus on harmonizing extraction protocols, developing standardized formulations, and generating robust clinical data through well-designed studies.

5. Conclusions

This comprehensive review demonstrates that numerous medicinal plants traditionally used in dermatological applications possess a wide range of pharmacologically active constituents, including flavonoids, phenolic acids, tannins, and sesquiterpenes. These compounds exhibit clinically relevant antioxidant, anti-inflammatory, antimicrobial, and wound-healing properties, supporting both historical ethnomedical practices and emerging evidence from modern pharmacological studies. The reviewed species, particularly those from Central Asian traditions, represent promising candidates for the development of novel dermatological and cosmeceutical formulations.
However, their clinical implementation requires addressing several challenges, including variability in plant material, lack of standardization protocols, and limited clinical validation. Future research should prioritize the development of reproducible extraction methods, precise phytochemical profiling, and well-designed clinical trials to confirm therapeutic efficacy and safety. In addition, identification of lead compounds, assessment of potential adverse effects and herb–drug interactions, and compliance with regulatory standards are essential steps toward translating traditional plant-based therapies into evidence-based dermatological practice.

Author Contributions

All authors conceptualized and designed this study: N.B., D.Sh., R.T., G.B. and M.D.—writing review and editing; D.B., T.V., N.I., G.B. and M.D.—drafting and revision of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was carried out within the framework of the grant funding project of the Ministry of Science and Higher Education of the Republic of Kazakhstan, contract No. 190/GF 24-26 AP23484003 “Development of new domestic, and environmentally friendly pharmacological substances for the treatment of skin diseases”.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Mias, C.; Mengeaud, V.; Bessou-Touya, S.; Duplan, H. Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway. J. Eur. Acad. Dermatol. Venereol. 2023, 37 (Suppl. S7), 3–11. [Google Scholar] [CrossRef]
  2. Courtney, A.; Su, J.C. The psychology of atopic dermatitis. J. Clin. Med. 2024, 13, 1602. [Google Scholar] [CrossRef]
  3. Coondoo, A.; Phiske, M.; Verma, S.; Lahiri, K. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol. Online, J. 2014, 5, 416–425. [Google Scholar] [CrossRef]
  4. Michalak, M. Plant extracts as skin care and therapeutic agents. Int. J. Mol. Sci. 2023, 24, 15444. [Google Scholar] [CrossRef]
  5. Olisova, O.Y.; Snarskaya, E.S.; Gladko, V.V.; Burova, E.P. Russian traditional medicine in dermatology. Clin. Dermatol. 2018, 36, 325–337. [Google Scholar] [CrossRef]
  6. Shedoeva, A.; Leavesley, D.; Upton, Z.; Fan, C. Wound healing and the use of medicinal plants. Evid. Based Complement. Altern. Med. 2019, 2019, 2684108. [Google Scholar] [CrossRef]
  7. Choi, H.Y.; Lee, Y.J.; Kim, C.M.; Lee, Y.-M. Revolutionizing Cosmetic Ingredients: Harnessing the Power of Antioxidants, Probiotics, Plant Extracts, and Peptides in Personal and Skin Care Products. Cosmetics 2024, 11, 157. [Google Scholar] [CrossRef]
  8. Cedillo-Cortezano, M.; Martinez-Cuevas, L.R.; López, J.A.M.; Barrera López, I.L.; Escutia-Perez, S.; Petricevich, V.L. Use of medicinal plants in the process of wound healing: A literature review. Pharmaceuticals 2024, 17, 303. [Google Scholar] [CrossRef]
  9. Iosageanu, A.; Mihai, E.; Seciu-Grama, A.M.; Utoiu, E.; Gaspar-Pintiliescu, A.; Gatea, F.; Craciunescu, O. In Vitro Wound-Healing Potential of Phenolic and Polysaccharide Extracts of Aloe vera Gel. J. Funct. Biomater. 2024, 15, 266. [Google Scholar] [CrossRef]
  10. Nisar, A.; Jagtap, S.; Vyavahare, S.; Deshpande, M.; Harsulkar, A.; Ranjekar, P.; Prakash, O. Phytochemicals in the treatment of inflammation-associated diseases: The journey from preclinical trials to clinical practice. Front. Pharmacol. 2023, 14, 1177050. [Google Scholar] [CrossRef]
  11. Gupta, B.; Malviya, R.; Mishra, P.S.; Uniyal, P. Plant-derived molecules as potent anti-skin cancer agents. A comprehensive review. Int. J. Mol. Sci. 2025, 26, 2278. [Google Scholar] [CrossRef]
  12. Koul, B.; Kumar, A.; Yadav, D.; Jin, J.O. Bergenia genus: Traditional uses, phytochemistry and pharmacology. Molecules 2020, 25, 5555. [Google Scholar] [CrossRef] [PubMed]
  13. Ajebli, M.; Eddouks, M. The promising role of plant tannins as bioactive antidiabetic agents. Curr. Med. Chem. 2019, 26, 4852–4884. [Google Scholar] [CrossRef]
  14. Kovaleva, T.Y.; Ermakova, V.A.; Dorovskih, E.A.; Trashchenkova, D.A.; Bokov, D.O.; Shilova, I.V.; Samylina, I.A. Phenolic Compounds and Biological Activity of Badan (Bergenia crassifolia (L.) Fritsch) Leaves Growing in Russia. Syst. Rev. Pharm. 2020, 11, 368. [Google Scholar] [CrossRef]
  15. Árok, R.; Végh, K.; Alberti, Á.; Kéry, Á. Phytochemical comparison and analysis of Bergenia crassifolia L. (Fritsch.) and Bergenia cordifolia Sternb. Eur. Chem. Bull. 2012, 1, 31–34. [Google Scholar]
  16. Stelmakh, S.; Ochirov, O.; Grigor’eva, M.; Tykheev, A.; Lebedeva, S.; Okladnikova, V.; Zhamsaranova, S. Wound-healing activity of polyhexamethyleneguanidine hydrochloride hydrogel and extract of Bergenia crassifolia on thermal burn simulation. Mong. J. Chem. 2022, 23, 51–62. [Google Scholar] [CrossRef]
  17. Liu, Y.; An, Z.; He, L.Y. The traditional uses, phytochemistry, pharmacology and toxicology of Bergenia purpurascens—A review. Heliyon 2023, 9, e22249. [Google Scholar] [CrossRef]
  18. Kushwaha, N.; Singh, A. Bergenia ciliata-phytochemistry and pharmacology: A review. Biomed. Mater. Devices 2024, 2, 891–904. [Google Scholar] [CrossRef]
  19. Mehta, S.; Kadian, V.; Dalal, S.; Dalal, P.; Kumar, S.; Garg, M.; Rao, R. A fresh look on bergenin: Vision of its novel drug delivery systems and pharmacological activities. Future Pharmacol. 2022, 2, 64–91. [Google Scholar] [CrossRef]
  20. Schmitzer, V.; Veberic, R.; Stampar, F. European elderberry (Plantago major L.) and American Elderberry (Sambucus canadensis L.): Botanical, chemical and health properties of flowers, berries and their products. In Berries: Properties, Consumption and Nutrition; Nova Science Publishers: New York, NY, USA, 2012; pp. 127–148. [Google Scholar]
  21. Svanberg, I.; de Vahl, E.; Ingvarsdóttir Olsen, N.; Ståhlberg, S. From Supernatural to Ornamental: Black Elder (Sambucus nigra L., Family Adoxaceae) in Sweden. Plants 2024, 13, 3068. [Google Scholar] [CrossRef]
  22. Ulbricht, C.; Basch, E.; Cheung, L.; Goldberg, H.; Hammerness, P.; Isaac, R.; Wortley, J. An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. J. Diet. Suppl. 2014, 11, 80–120. [Google Scholar] [CrossRef]
  23. Knudsen, B.F.; Kaack, K.V. A review of human health and disease claims for elderberry (Sambucus nigra) fruit. In Proceedings of the I International Symposium on Elderberry, Warsaw, Poland, 9–14 June 2013. [Google Scholar] [CrossRef]
  24. Zwolińska, D. Rational phytotherapy as an alternative treatment for acute respiratory tract infections. Paediatr. Fam. Med. 2022, 18, 139. [Google Scholar] [CrossRef]
  25. Skowrońska, W.; Granica, S.; Czerwińska, M.E.; Osińska, E.; Bazylko, A. Sambucus nigra L. leaves inhibit TNF-α secretion by LPS-stimulated human neutrophils and strongly scavenge reactive oxygen species. J. Ethnopharmacol. 2022, 290, 115116. [Google Scholar] [CrossRef] [PubMed]
  26. Mota, A.H.; Andrade, J.M.; Ntungwe, E.N.; Pereira, P.; Cebola, M.J.; Bernardo-Gil, M.G.; Reis, C.P. Green extraction of Sambucus nigra L. for potential application in skin nanocarriers. Green Mater. 2020, 8, 181–193. [Google Scholar] [CrossRef]
  27. Lin, P.; Hwang, E.; Ngo, H.T.; Seo, S.A.; Yi, T.H. Sambucus nigra L. ameliorates UVB-induced photoaging and inflammatory response in human skin keratinocytes. Cytotechnology 2019, 71, 1003–1017. [Google Scholar] [CrossRef]
  28. Bejenaru, C.; Radu, A.; Mogoşanu, G.D.; Bejenaru, L.E.; Biţă, A.; Segneanu, A.E. Plantaginaceae Juss. Family. In Natural Products and Medicinal Properties of Carpathian (Romanian) Plants; CRC Press: Boca Raton, FL, USA, 2024; pp. 309–318. [Google Scholar]
  29. Upadhyay, S.; Bhandari, S.; Sharma, A.; Singh, B.R.; Taj, G. Plantago lanceolata L. In Medicinal and Aromatic Plants of India; Springer Nature Switzerland: Cham, Switzerland, 2024; Volume 3, pp. 287–301. [Google Scholar] [CrossRef]
  30. Cardoso, F.C.; Bortolozo, B.B.; Morari, J.; e Silva, G.T.D.S.; Rosa, P.C.; Araujo, E.P.; Lima, M.H. Effect of Plantago major on wound healing in hyperglycemic mice. J. Biosci. Med. 2025, 13, 320–333. [Google Scholar] [CrossRef]
  31. Michielini, J.P.; Yi, X.; Brown, L.M.; Gao, S.M.; Orians, C.; Crone, E.E. Novel host plant use by a specialist insect depends on geographic variation in both the host and herbivore species. Oecologia 2024, 204, 95–105. [Google Scholar] [CrossRef]
  32. Gasiewska, E.; Varga, S.; de Graaf, B.H.; Sánchez Vilas, J. Effects of water limitation on the production of key secondary metabolites with medicinal properties in Plantago lanceolata and Tanacetum parthenium. All Life 2025, 18, 2467653. [Google Scholar] [CrossRef]
  33. Gupta, S.; Singh, R.; Sharma, A.; Rather, G.A.; Lattoo, S.K.; Dhar, M.K. Comparative transcriptome mining for terpenoid biosynthetic pathway genes in wild and cultivated species of Plantago. Protoplasma 2022, 259, 439–452. [Google Scholar] [CrossRef]
  34. Samuelsen, A.B. The traditional uses, chemical constituents and biological activities of Plantago major L. A review. J. Ethnopharmacol. 2000, 71, 1–21. [Google Scholar] [CrossRef]
  35. Noureddine, B.; Elachouri, M.; Bussmann, R.W.; Khojimatov, O.K. Plantago afra L., Plantago akkensis subsp. ounifensis (Batt.) Maire, Plantago albicans L., Plantago amplexicaulis Cav., Plantago ciliata Desf., Plantago coronopus L., Plantago lanceolata L., Plantago major L., Plantago ovata Forssk. Plantaginaceae. In Ethnobotany of Northern Africa and Levant; Springer International Publishing: Cham, Switzerland, 2024; pp. 1–24. [Google Scholar] [CrossRef]
  36. Tian, Z.; Cheng, J.; Xu, J.; Feng, D.; Zhong, J.; Yuan, X.; Qiang, S. Cytogeography of naturalized Solidago canadensis populations in Europe. Plants 2023, 12, 1113. [Google Scholar] [CrossRef] [PubMed]
  37. Nkuimi Wandjou, J.G.; Quassinti, L.; Gudžinskas, Z.; Nagy, D.U.; Cianfaglione, K.; Bramucci, M.; Maggi, F. Chemical composition and antiproliferative effect of essential oils of four Solidago species (S. canadensis, S. gigantea, S. virgaurea and S.× niederederi). Chem. Biodivers. 2020, 17, e2000685. [Google Scholar] [CrossRef] [PubMed]
  38. Zhu, X.; Li, W.; Shao, H.; Tang, S. Selected aspects of invasive Solidago canadensis with an emphasis on its allelopathic abilities: A review. Chem. Biodivers. 2022, 19, e202200728. [Google Scholar] [CrossRef]
  39. Likhanov, A.; Oliinyk, M.; Pashkevych, N.; Churilov, A.; Kozyr, M. The role of flavonoids in invasion strategy of Solidago canadensis L. Plants 2021, 10, 1748. [Google Scholar] [CrossRef]
  40. Fedina, L.A.; Kuprin, A.V.; Ogorodnikov, E.M. Tussilago farfara (Asteraceae) in the South of the Far East of Russia. Russ. J. Biol. Invasions 2020, 11, 88–91. [Google Scholar] [CrossRef]
  41. Stoyanova, M.A.; Perifanova-Nemska, M.N. Biologically active compounds from Tussilago farfara L. IOP Conf. Ser. Mater. Sci. Eng. 2021, 1031, 012103. [Google Scholar] [CrossRef]
  42. Chen, S.; Dong, L.; Quan, H.; Zhou, X.; Ma, J.; Xia, W.; Fu, X. A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot). J. Ethnopharmacol. 2021, 267, 113478. [Google Scholar] [CrossRef]
  43. Liu, Y.F.; Yang, X.W.; Wu, B. Chemical constituents of the flower buds of Tussilago farfara. J. Chin. Pharm. Sci. 2007, 16, 288. [Google Scholar]
  44. Chanaj-Kaczmarek, J.; Wojcińska, M.; Matlawska, I. Phenolics in the Tussilago farfara leaves. Herba Pol. 2013, 59. [Google Scholar] [CrossRef]
  45. Das, R.; Kemisetti, D. A comprehensive review Tussilago farfara Linn.: Taxonomical, morphological classification and its pharmacological activities. Res. Rev. Plant Sci. 2024, 4, 88. [Google Scholar]
  46. Sõukand, R.; Hrynevich, Y.; Vasilyeva, I.; Prakofjewa, J.; Vnukovich, Y.; Paciupa, J.; Kalle, R. Multi-functionality of the few: Current and past uses of wild plants for food and healing in Liubań region, Belarus. J. Ethnobiol. Ethnomed. 2017, 13, 10. [Google Scholar] [CrossRef] [PubMed]
  47. Meng, Q.; Manghwar, H.; Hu, W. Study on supergenus Rubus, L.: Edible, medicinal, and phylogenetic characterization. Plants 2022, 11, 1211. [Google Scholar] [CrossRef] [PubMed]
  48. Bolatkyzy, N.; Nurmakhanova, A.; Berganayeva, G.; Dyusebaeva, M. Study of the chemical composition of the Rubus vulgaris plant. Chem. J. Kaz. 2024, 1, 77–88. [Google Scholar] [CrossRef]
  49. Graham, J.; Woodhead, M. Rubus. In Wild Crop Relatives: Genomic and Breeding Resources: Temperate Fruits; Springer: Berlin/Heidelberg, Germany, 2010; pp. 179–196. [Google Scholar] [CrossRef]
  50. Surya, M.I.; Suhartati, S.; Ismaini, L.; Lusini, Y.; Anggraeni, D.; Normasiwi, S.; Bakar Sidiq, M.A. Fruit nutrients of five species of wild raspberries (Rubus spp.) from Indonesian mountain’s forests. J. Trop. Life Sci. 2018, 8, 75–80. [Google Scholar] [CrossRef]
  51. Gudej, J.; Tomczyk, M. Determination of flavonoids, tannins and ellagic acid in leaves from Rubus, L. species. Arch. Pharm. Res. 2004, 27, 1114–1119. [Google Scholar] [CrossRef]
  52. Muniyandi, K.; George, E.; Sathyanarayanan, S.; George, B.P.; Abrahamse, H.; Thamburaj, S.; Thangaraj, P. Phenolics, tannins, flavonoids and anthocyanins contents influenced antioxidant and anticancer activities of Rubus fruits from Western Ghats, India. Food Sci. Hum. Wellness 2019, 8, 73–81. [Google Scholar] [CrossRef]
  53. Zafrilla, P.; Ferreres, F.; Tomás-Barberán, F.A. Effect of processing and storage on the antioxidant ellagic acid derivatives and flavonoids of red raspberry (Rubus idaeus) jams. J. Agric. Food Chem. 2001, 49, 3651–3655. [Google Scholar] [CrossRef]
  54. Gil-Martínez, L.; Mut-Salud, N.; Ruiz-García, J.A.; Falcón-Piñeiro, A.; Maijó-Ferré, M.; Baños, A.; Gómez-Caravaca, A.M. Phytochemicals determination, and antioxidant, antimicrobial, anti-inflammatory and anticancer activities of blackberry fruits. Foods 2023, 12, 1505. [Google Scholar] [CrossRef]
  55. Süntar, I.; Koca, U.; Keleş, H.; Akkol, E.K. Wound healing activity of Rubus sanctus Schreber (Rosaceae): Preclinical study in animal models. Evid. Based Complement. Alternat. Med. 2011, 2011, 816156. [Google Scholar] [CrossRef]
  56. Pozdnyakova, Y.; Sailau, A.; Solyanov, D.; Aitisheva, L.; Tatina, Y.; Britko, V. Diversity of early flowering plants of the Ulytau mountains (Central Kazakhstan). Biosyst. Divers. 2023, 31, 261–268. [Google Scholar] [CrossRef]
  57. Martinez, M.; Poirrier, P.; Chamy, R.; Prüfer, D.; Schulze-Gronover, C.; Jorquera, L.; Ruiz, G. Taraxacum officinale and related species—An ethnopharmacological review and its potential as a commercial medicinal plant. J. Ethnopharmacol. 2015, 169, 244–262. [Google Scholar] [CrossRef] [PubMed]
  58. Williams, C.A.; Goldstone, F.; Greenham, J. Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale. Phytochemistry 1996, 42, 121–127. [Google Scholar] [CrossRef] [PubMed]
  59. Sun, Z.; Su, R.; Qiao, J.; Zhao, Z.; Wang, X. Flavonoids extraction from Taraxacum officinale (dandelion): Optimisation using response surface methodology and antioxidant activity. J. Chem. 2014, 2014, 956278. [Google Scholar] [CrossRef]
  60. Wu, J. Antibacterial activity of Taraxacum officinale against foodborne pathogens. Pak. J. Zool. 2021, 54, 1–8. [Google Scholar] [CrossRef]
  61. Díaz, K.; Espinoza, L.; Madrid, A.; Pizarro, L.; Chamy, R. Isolation and identification of compounds from bioactive extracts of Taraxacum officinale Weber ex F.H. Wigg. (dandelion) as a potential source of antibacterial agents. Evid. Based Complement. Alternat. Med. 2018, 2018, 2706417. [Google Scholar] [CrossRef]
  62. Di Napoli, A.; Zucchetti, P. A comprehensive review of the benefits of Taraxacum officinale on human health. Bull. Natl. Res. Cent. 2021, 45, 110. [Google Scholar] [CrossRef]
  63. Sweeney, B.; Vora, M.; Ulbricht, C.; Basch, E. Evidence-based systematic review of dandelion (Taraxacum officinale) by Natural Standard Research Collaboration. J. Herb. Pharmacother. 2005, 5, 79–93. [Google Scholar] [CrossRef]
  64. Grudzinskaya, L.M.; Gemejiyeva, N.G.; Karzhaubekova, Z.Z. The Kazakhstan medicinal flora survey in a leading families volume. Bull. Karaganda Univ. Biol. Med. Geogr. Ser. 2020, 100, 39–51. [Google Scholar] [CrossRef]
  65. Zajac, T.; Oleksy, A.; Klimek-Kopyra, A.; Kulig, B. Biological determinants of plant and crop productivity of flax (Linum usitatissimum L.). Acta Agrobot. 2012, 65, 3–14. [Google Scholar] [CrossRef]
  66. Jhala, A.J.; Hall, L.M. Flax (Linum usitatissimum L.): Current uses and future applications. Aust. J. Basic Appl. Sci. 2010, 4, 4304–4312. [Google Scholar]
  67. Hussain, S.; Anjum, F.M.; Butt, M.S.; Sheikh, M.A. Chemical composition and functional properties of flaxseed (Linum usitatissimum) flour. Sarhad J. Agric. 2008, 24, 649–653. [Google Scholar]
  68. Hussien, Z.G.; Aziz, R.A. Chemical composition and antibacterial activity of Linum usitatissimum L. (Flaxseed). Syst. Rev. Pharm. 2021, 12, 145–147. [Google Scholar]
  69. Herchi, W.; Bahashwan, S.; Sebei, K.; Saleh, H.B.; Kallel, H.; Boukhchina, S. Effects of germination on chemical composition and antioxidant activity of flaxseed (Linum usitatissimum L.) oil. Grasas Aceites 2015, 66, e057. [Google Scholar] [CrossRef]
  70. Sharil, A.T.M.; Ezzat, M.B.; Widya, L.; Nurhakim, M.H.A.; Hikmah, A.R.N.; Zafira, Z.N.; Haris, M.S. Systematic review of flaxseed (Linum usitatissimum L.) extract and formulation in wound healing. J. Pharm. Pharmacogn. Res. 2022, 10, 1–12. [Google Scholar] [CrossRef] [PubMed]
  71. Gürbüz, İ.L.H.A.N.; Özkan, A.M.G.; Akaydin, G.; Salihoğlu, E.C.E.; Günbatan, T.U.Ğ.B.A.; Demirci, F.; Yeşilada, E. Folk medicine in Düzce province (Turkey). Turk. J. Bot. 2019, 43, 769–784. [Google Scholar] [CrossRef]
  72. Kajszczak, D.; Zakłos-Szyda, M.; Podsędek, A. Viburnum opulus L.—A review of phytochemistry and biological effects. Nutrients 2020, 12, 3398. [Google Scholar] [CrossRef]
  73. Kollmann, J.; Grubb, P.J. Viburnum lantana L. and Viburnum opulus L. (V. lobatum Lam., Opulus vulgaris Borkh.). J. Ecol. 2002, 90, 1044–1070. [Google Scholar] [CrossRef]
  74. Vijaytha, V.; Anupama, R.V.; Haridas, M. Phytochemical profiling, and antioxidant, antibacterial, and anti-inflammatory properties of Viburnum coriaceum Blume. Future J. Pharm. Sci. 2020, 6, 84. [Google Scholar] [CrossRef]
  75. Sharifi-Rad, J.; Quispe, C.; Vergara, C.V.; Kitic, D.; Kostic, M.; Armstrong, L.; Cho, W.C. Genus Viburnum: Therapeutic potentialities and agro-food-pharma applications. Oxid. Med. Cell. Longev. 2021, 2021, 3095514. [Google Scholar] [CrossRef]
  76. Tkacheva, N.; Eliseeva, T. Kalina (Viburnum). J. Healthy Nutr. Diet. 2018, 3, 43–52. [Google Scholar] [CrossRef]
  77. Akat, F.; Almaghrebi, E. Exploring the Therapeutic Potential of Viburnum opulus L.: A Comprehensive Review of Its Medicinal Properties and Health Benefits. In Traditional Medicine in North East Africa; Bentham Science Publishers: Sharjah, United Arab Emirates, 2025; pp. 147–171. [Google Scholar] [CrossRef]
  78. Moldovan, B.; David, L.; Vulcu, A.; Olenic, L.; Perde-Schrepler, M.; Fischer-Fodor, E.; Filip, G.A. In vitro and in vivo anti-inflammatory properties of green synthesized silver nanoparticles using Viburnum opulus L. fruits extract. Mater. Sci. Eng. C 2017, 79, 720–727. [Google Scholar] [CrossRef] [PubMed]
  79. Khvorost, O.; Shpychak, O.; Skrebtsova, K. Prospects for using the fruits of Viburnum opulus to obtain medicines of various directions of action. Ann. Mechnikov’s Inst. 2024, 4, 11–15. [Google Scholar] [CrossRef]
  80. Aćimović, M.; Rat, M.; Pezo, L.; Lončar, B.; Pezo, M.; Miljković, A.; Lazarević, J. Biological and chemical diversity of Angelica archangelica L.—Case study of essential oil and its biological activity. Agronomy 2022, 12, 1570. [Google Scholar] [CrossRef]
  81. Maurya, A.; Verma, S.C.; Gupta, V.; Shankar, M.B. Angelica archangelica L.—A phytochemical and pharmacological review. Asian J. Res. Chem. 2017, 10, 852–856. [Google Scholar] [CrossRef]
  82. Forycka, A.; Buchwald, W. Variability of composition of essential oil and coumarin compounds of Angelica archangelica L. Herba Pol. 2019, 65, 4. [Google Scholar] [CrossRef]
  83. Nurzyńska-Wierdak, R. Chemical diversity, yield, and quality of aromatic plants. Agronomy 2023, 13, 1614. [Google Scholar] [CrossRef]
  84. Mamache, W.; Benslama, A.; Benchikh, F.; Benabdellah, H.; Lassas, S.; Amira, H.; Amira, S. Phytochemical screening, antioxidant, anti-ulcer, anti-inflammatory and analgesic activity of the aqueous extract of Angelica archangelica. Turk. J. Agric. Food Sci. Technol. 2022, 10, 334–340. [Google Scholar] [CrossRef]
  85. Sowndhararajan, K.; Deepa, P.; Kim, M.; Park, S.J.; Kim, S. A review of the composition of the essential oils and biological activities of Angelica species. Sci. Pharm. 2017, 85, 33. [Google Scholar] [CrossRef]
  86. Mishra, A.K.; Paliwal, S.K. A deep insight into chemistry and pharmacology of genus Angelica: An up-to-date systematic review. Nat. Prod. J. 2025, 15, e190324228133. [Google Scholar] [CrossRef]
  87. Topal, M.; Ozturk Sarıkaya, S.B.; Topal, F. Determination of Angelica archangelica’s antioxidant capacity and mineral content. ChemistrySelect 2021, 6, 7976–7980. [Google Scholar] [CrossRef]
  88. Kaur, A.; Bhatti, R. Understanding the phytochemistry and molecular insights to the pharmacology of Angelica archangelica L. (garden angelica) and its bioactive components. Phytother. Res. 2021, 35, 5961–5979. [Google Scholar] [CrossRef]
  89. Mir, S.A.; Dar, L.A.; Ali, T.; Kareem, O.; Rashid, R.; Khan, N.A.; Bader, G.N. Arctium lappa: A review on its phytochemistry and pharmacology. In Edible Plants in Health and Diseases: Volume II: Phytochemical and Pharmacological Properties; Springer Nature: Singapore, 2022; pp. 327–348. [Google Scholar] [CrossRef]
  90. Abdikerim, M.; Azimbaeva, G.; Izteleu, B.; Smailova, K. Comprehensive study of the main biologically active compounds in Arctium lappa plants growing in Kazakhstan. Pak. J. Bot. 2024, 56, 611–620. [Google Scholar] [CrossRef]
  91. Su, Y.; Fu, J.; Xie, H.; Huang, Z.; Li, Y.; Luo, Y.; Liu, Y. SSR markers development and their application in genetic diversity of burdock (Arctium lappa L.) germplasm. BMC Plant Biol. 2025, 25, 196. [Google Scholar] [CrossRef] [PubMed]
  92. Shukla, S.; Kakade, M.; Cherian, S.; Alagarasu, K.; Parashar, D. Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication. Phytomedicine 2024, 128, 155491. [Google Scholar] [CrossRef] [PubMed]
  93. Balkrishna, A.; Rana, M.; Mishra, S.; Rajput, S.K.; Dhanasekaran, M. Arctigenin: Harnessing nature’s power as an anti-inflammatory agent. Curr. Res. Complement. Altern. Med. 2024, 8, 255. [Google Scholar] [CrossRef]
  94. Zhao, F.; Wang, L.; Liu, K. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition of the iNOS pathway. J. Ethnopharmacol. 2009, 122, 457–462. [Google Scholar] [CrossRef]
  95. Zhao, N.; Wang, L.; Cock, I.E. Arctium lappa L. root extracts inhibit the growth of bacterial triggers of selected autoimmune inflammatory diseases and potentiate the activity of conventional antibiotics. Pharmacogn. Commun. 2021, 11, 195–204. [Google Scholar] [CrossRef]
  96. Knipping, K.; van Esch, E.C.; Wijering, S.C.; van der Heide, S.; Dubois, A.E.; Garssen, J. In vitro and in vivo anti-allergic effects of Arctium lappa L. Exp. Biol. Med. 2008, 233, 1469–1477. [Google Scholar] [CrossRef]
  97. Sorokopudov, V.; Kabanov, A.; Bamatov, I. Features of the introduction of representatives of the genus Inula, L. BIO Web Conf. 2021, 32, 01001. [Google Scholar] [CrossRef]
  98. Verkhozina, A.V.; Anisimov, A.V.; Beshko, N.Y.; Biryukov, R.Y.; Bondareva, V.V.; Chernykh, D.V.; Dorofeev, N.V.; Dorofeyev, V.I.; Ebel, A.L.; Efremo, A.N.; et al. Findings to the flora of Russia and adjacent countries: New national and regional vascular plant records, 4. Bot. Pacifica 2022, 11, 129–157. [Google Scholar] [CrossRef]
  99. Dao, T.T.; Song, K.; Kim, J.Y.; Kim, Y.S. Igalan from Inula helenium L. suppresses the atopic-dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling. Inflamm. Res. 2020, 69, 309–319. [Google Scholar] [CrossRef]
  100. Buza, V.; Matei, M.C.; Ștefănuț, L.C. Inula helenium: A literature review on ethnomedical uses, bioactive compounds and pharmacological activities. Lucr. Științ. Ser. Med. Vet. 2020, 63, 53–59. [Google Scholar]
  101. Halagali, P.; Tippavajhala, V.K.; Rathnanand, M.; Sharma, H.; Pathak, R. Inulin as a Natural Ingredient in Cosmetics and Personal Care Products. In Inulin for Pharmaceutical Applications: A Versatile Biopolymer; Springer Nature: Singapore, 2025; pp. 137–146. [Google Scholar] [CrossRef]
  102. Kenny, C.-R.; Stojakowska, A.; Furey, A.; Lucey, B. From Monographs to Chromatograms: The Antimicrobial Potential of Inula helenium L. (Elecampane) Naturalised in Ireland. Molecules 2022, 27, 1406. [Google Scholar] [CrossRef] [PubMed]
  103. Petkova, N.; Ivanov, I.; Vrancheva, R.; Denev, P.; Pavlov, A. Ultrasound and microwave-assisted extraction of elecampane (Inula helenium) roots. Nat. Prod. Commun. 2017, 12, 1934578X1701200207. [Google Scholar] [CrossRef]
  104. Paulsen, E. Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermat. 2002, 47, 189–198. [Google Scholar] [CrossRef]
  105. Dyakova, N.A.; Gaponov, S.P.; Slivkin, A.I.; Belenova, A.S.; Karlov, P.M.; Lavrov, S.V. Elaboration of an express technique for inulin extraction from the roots of elecampane (Inula helenium L.). IOP Conf. Ser. Earth Environ. Sci. 2021, 640, 052021. [Google Scholar] [CrossRef]
  106. Kianitalaei, A.; Feyzabadi, Z.; Hamedi, S.; Qaraaty, M.J.J.A.P.E.R. Althaea officinalis in traditional medicine and modern phytotherapy. J. Adv. Pharm. Educ. Res. 2019, 9 (Suppl. S2), 155. [Google Scholar]
  107. Xue, T.; Ruan, K.; Tang, Z.; Duan, J.; Xu, H. Isolation, structural properties, and bioactivities of polysaccharides from Althaea officinalis Linn.: A review. Int. J. Biol. Macromol. 2023, 242, 125098. [Google Scholar] [CrossRef]
  108. Naseri, V.; Chavoshzadeh, Z.; Mizani, A.; Daneshfard, B.; Ghaffari, F.; Abbas-Mohammadi, M.; Naseri, M. Effect of topical marshmallow (Althaea officinalis) on atopic dermatitis in children: A pilot double-blind active-controlled clinical trial of an in-silico-analyzed phytomedicine. Phytother. Res. 2021, 35, 1389–1398. [Google Scholar] [CrossRef]
  109. Farhat, C.; Younes, H.; Alyamani, O.A.; Mrad, M.; Hourani, N.; Khalifeh, H.; Hage-Sleiman, R. Chemical characterization and in vitro biological evaluation of aqueous extract of Althaea officinalis L. flower grown in Lebanon. J. Herb. Med. 2022, 34, 100575. [Google Scholar] [CrossRef]
  110. Khalighi, N.; Jabbari-Azad, F.; Barzegar-Amini, M.; Tavakkol-Afshari, J.; Layegh, P.; Salari, R. Impact of Althaea officinalis extract in patients with atopic eczema: A double-blind randomized controlled trial. Clin. Phytosci. 2021, 7, 73. [Google Scholar] [CrossRef]
  111. Doe, J.; Smith, A. High-Value Phytochemicals and Nutraceutical–Pharmaceutical Prospects of Althaea officinalis L. (Marshmallow): A Review. J. Pharm. Biomed. Anal. 2025, 234, 103601. [Google Scholar] [CrossRef]
  112. Bonaterra, G.A.; Bronischewski, K.; Hunold, P.; Schwarzbach, H.; Heinrich, E.U.; Fink, C.; Kinscherf, R. Anti-inflammatory and anti-oxidative effects of Phytohustil® and root extract of Althaea officinalis L. on macrophages in vitro. Front. Pharmacol. 2020, 11, 290. [Google Scholar] [CrossRef] [PubMed]
  113. Bonaterra, G.A.; Schmitt, J.; Schneider, K.; Schwarzbach, H.; Aziz-Kalbhenn, H.; Kelber, O.; Kinscherf, R. Phytohustil® and root extract of Althaea officinalis L. exert anti-inflammatory and anti-oxidative properties and improve the migratory capacity of endothelial cells in vitro. Front. Pharmacol. 2022, 13, 948248. [Google Scholar] [CrossRef] [PubMed]
  114. Crișan, I.; Ona, A.; Vârban, D.; Muntean, L.; Vârban, R.; Stoie, A.; Morea, A. Current trends for lavender (Lavandula angustifolia Mill.) crops and products with emphasis on essential oil quality. Plants 2023, 12, 357. [Google Scholar] [CrossRef]
  115. Yegorova, N.A.; Mitrofanova, I.V.; Brailko, V.A.; Grebennikova, O.A.; Paliy, A.E.; Stavtseva, I.V. Morphogenetic, physiological, and biochemical features of Lavandula angustifolia at long-term micropropagation in vitro. Russ. J. Plant Physiol. 2019, 66, 326–334. [Google Scholar] [CrossRef]
  116. Jianu, C.; Pop, G.; Gruia, A.T.; Horhat, F.G. Chemical composition and antimicrobial activity of essential oils of lavender (Lavandula angustifolia) and lavandin (Lavandula × intermedia) grown in Western Romania. Int. J. Agric. Biol. 2013, 15, 772–776. [Google Scholar]
  117. TienVinh, D.; Hoa, M.T.; Khai, P.C.; Van Minh, T. Micropropagation of lavender (Lavandula angustifolia). Seeds 2017, 4, 7–11. [Google Scholar]
  118. Adaszyńska, M.; Swarcewicz, M.; Dobrowolska, A. Chemical and mineral composition in varieties of lavender (Lavandula angustifolia L.). Prog. Plant Prot. 2011, 51, 15–20. [Google Scholar]
  119. Cardia, G.F.E.; Silva-Filho, S.E.; Silva, E.L.; Uchida, N.S.; Cavalcante, H.A.O.; Cassarotti, L.L.; Cuman, R.K.N. Effect of lavender (Lavandula angustifolia) essential oil on acute inflammatory response. Evid. Based Complement. Alternat. Med. 2018, 2018, 1413940. [Google Scholar] [CrossRef]
  120. Sharma, L.; Chandra, M.; Puneeta, A. Health benefits of lavender (Lavandula angustifolia). Int. J. Physiol. Nutr. Phys. Educ. 2020, 4, 1274–1277. [Google Scholar]
  121. Andrei, F.; Ersilia, A.; Tulcan, C.; Dragomirescu, A. Chemical composition and the potential of Lavandula angustifolia L. oil as a skin depigmentant. Rec. Nat. Prod. 2018, 12, 340. [Google Scholar] [CrossRef]
  122. Galea, C.; Cocoș, D.I.; Feier, F.; Moales, D. The use of essential oils in the development of dermato-cosmetic products. Med. Mater. 2023, 3, 31–36. [Google Scholar] [CrossRef]
  123. Vlaisavljević, S.; Kaurinović, B.; Popović, M.; Vasiljević, S. Profile of phenolic compounds in Trifolium pratense L. extracts at different growth stages and their biological activities. Int. J. Food Prop. 2017, 20, 3090–3101. [Google Scholar] [CrossRef]
  124. McKenna, P.; Cannon, N.; Conway, J.; Dooley, J.; Davies, W.P. Red clover (Trifolium pratense) in conservation agriculture: A compelling case for increased adoption. Int. J. Agric. Sustain. 2018, 16, 342–366. [Google Scholar] [CrossRef]
  125. Antonescu, A.I.; Miere, F.; Fritea, L.; Ganea, M.; Zdrinca, M.; Dobjanschi, L.; Cavalu, S. Perspectives on the combined effects of Ocimum basilicum and Trifolium pratense extracts in terms of phytochemical profile and pharmacological effects. Plants 2021, 10, 1390. [Google Scholar] [CrossRef]
  126. Gligor, D.; Kazlauskaite, J.A.; Bernatoniene, J.; Ivanauskas, L. Multidirectional Effects of Trifolium pratense L. (Red Clover) Extracts: Antioxidant, Estrogenic and Metabolic Activities. Molecules 2023, 28, 5178. [Google Scholar] [CrossRef]
  127. Dlamini, Z.; Jancsó, M.; Székely, Á.; Kolozsvári, I.; Túri, N.; Bakti, B.; Zalai, M.; Kun, Á. Assessing Yield, Biomass Production, and Forage Quality of Red Clover (Trifolium pratense L.) in Agroforestry System: One-Year Study in Szarvas, Hungary. Agronomy 2024, 14, 1921. [Google Scholar] [CrossRef]
  128. Manzoureh, R.; Farahpour, M.R. Topical administration of hydroethanolic extract of Trifolium pratense (red clover) accelerates wound healing by apoptosis and re-epithelialization. Biotech. Histochem. 2021, 96, 276–286. [Google Scholar] [CrossRef]
  129. Antonescu, A.I.M.; Antonescu, A.; Miere, F.G.; Fritea, L.; Teodorescu, A.G.; Vicas, L.; Cavalu, S. Novel topical formulations based on O. basilicum and T. pratense: Antioxidant, antimicrobial, and anti-inflammatory effect. Pharmacophore 2022, 13, 80–90. [Google Scholar] [CrossRef]
  130. Wen, J.; Shi, S. A phylogenetic and biogeographic study of Hamamelis (Hamamelidaceae), an eastern Asian and eastern North American disjunct genus. Biochem. Syst. Ecol. 1999, 27, 55–66. [Google Scholar] [CrossRef]
  131. Li, J.; Bogle, A.L.; Klein, A.S.; Donoghue, M.J. Phylogeny and biogeography of Hamamelis (Hamamelidaceae). Harv. Pap. Bot. 2000, 5, 171–178. [Google Scholar]
  132. Abbas, T.F.; Abbas, M.F.; Lafta, A.J. Antibacterial activity and medical properties of Witch Hazel Hamamelis virginiana. Ann. Trop. Med. Public Health 2020, 23, 46. [Google Scholar] [CrossRef]
  133. Natella, F.; Guantario, B.; Ambra, R.; Ranaldi, G.; Intorre, F.; Burki, C.; Canali, R. Human metabolites of Hamaforton™ (Hamamelis virginiana L. Extract) modulate fibroblast extracellular matrix components in response to UV-A irradiation. Front. Pharmacol. 2021, 12, 747638. [Google Scholar] [CrossRef] [PubMed]
  134. Piazza, S.; Martinelli, G.; Vrhovsek, U.; Masuero, D.; Fumagalli, M.; Magnavacca, A.; Sangiovanni, E. Anti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes. Antioxidants 2022, 11, 1119. [Google Scholar] [CrossRef] [PubMed]
  135. Trüeb, R.M. Efficacy, tolerability, and superiority of propylene glycol-free, North American witch-hazel (Hamamelis virginiana)-based solution of 5% minoxidil sulfate for the treatment of female androgenetic alopecia. Int. J. Trichol. 2023, 15, 108–112. [Google Scholar] [CrossRef]
  136. Arct, J.; Pytkowska, K.; Dzierzgowski, S.; Neofitna, M. Oczar wirginijski (Hamamelis virginiana) w kosmetyce. Pol. J. Cosmetol. 2018, 21, 139–144. [Google Scholar]
  137. Turan, Ç.; Öner, Ü. Lip mesotherapy with dexpanthenol as a novel approach to prevent isotretinoin-associated cheilitis. Dermatol. Pract. Concept. 2023, 13, e2023012. [Google Scholar] [CrossRef]
  138. Otfinowski, R.K.N.C.C.P.M.; Kenkel, N.C.; Catling, P.M. The biology of Canadian weeds. 134 Bromus inermis Leyss. Can. J. Plant Sci. 2007, 87, 183–198. [Google Scholar] [CrossRef]
  139. Vasylenko, N.; Averchev, O.; Lavrenko, S.; Avercheva, N.; Lavrenko, N. Growth, Development and Productivity of Bromus inermis Depending on the Elements of Growing Technology in Non-Irradiated Conditions. 2020. Available online: https://www.agrolifejournal.usamv.ro/index.php/agrolife/article/view/714 (accessed on 15 December 2020).
  140. Mackiewicz-Walec, E.; Żarczyński, P.J.; Krzebietke, S.J.; Żarczyńska, K. Smooth Brome (Bromus inermis L.)—A versatile grass: A review. Agriculture 2024, 14, 854. [Google Scholar] [CrossRef]
  141. Mosse, I.B.; Sedlyar, N.I.; Babenko, A.S.; Mosse, K.A.; Kilchevsky, A.V. Determination of Epigenetic Markers of Human Psychoemotional Status; JINR: Dubna, Russia, 2021; p. 48. [Google Scholar]
  142. Mueller, R.S.; Bettenay, S.V.; Tideman, L. Aero-allergens in canine atopic dermatitis in southeastern Australia based on 1000 intradermal skin tests. Aust. Vet. J. 2000, 78, 392–399. [Google Scholar] [CrossRef]
  143. Ahmed, K.M.; Gupta, B.M.; Gupta, R. Curcuma longa (medicinal plant) research: A scientometric assessment of global publications output during 1997–2016. Pharmacogn. J. 2018, 10, 998–1006. [Google Scholar] [CrossRef]
  144. Ayer, D.K. Breeding for quality improvement in turmeric (Curcuma longa L.): A review. Adv. Plants Agric. Res. 2017, 6, 201–204. [Google Scholar] [CrossRef]
  145. Hossain, M.A.; Ishimine, Y. Growth, yield and quality of turmeric (Curcuma longa L.) cultivated on dark-red soil, gray soil and red soil in Okinawa, Japan. Plant Prod. Sci. 2005, 8, 482–486. [Google Scholar] [CrossRef]
  146. Li, S.; Yuan, W.; Deng, G.; Wang, P.; Yang, P.; Aggarwal, B. Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharm. Crop. 2011, 2, 28–54. [Google Scholar] [CrossRef]
  147. Albaqami, J.J.; Hamdi, H.; Narayanankutty, A.; Visakh, N.U.; Sasidharan, A.; Kuttithodi, A.M.; Pathrose, B. Chemical composition and biological activities of the leaf essential oils of Curcuma longa, Curcuma aromatica and Curcuma angustifolia. Antibiotics 2022, 11, 1547. [Google Scholar] [CrossRef]
  148. Dosoky, N.S.; Setzer, W.N. Chemical composition and biological activities of essential oils of Curcuma species. Nutrients 2018, 10, 1196. [Google Scholar] [CrossRef]
  149. Gounder, D.K.; Lingamallu, J. Comparison of chemical composition and antioxidant potential of volatile oil from fresh, dried and cured turmeric (Curcuma longa) rhizomes. Ind. Crops Prod. 2012, 38, 124–131. [Google Scholar] [CrossRef]
  150. Gopinath, H.; Karthikeyan, K. Turmeric: A condiment, cosmetic and cure. Indian J. Dermatol. Venereol. Leprol. 2018, 84, 16. [Google Scholar] [CrossRef]
  151. Zaman, S.U.; Akhtar, N. Effect of turmeric (Curcuma longa Zingiberaceae) extract cream on human skin sebum secretion. Trop. J. Pharm. Res. 2013, 12, 665–669. [Google Scholar] [CrossRef]
  152. Asada, K.; Ohara, T.; Muroyama, K.; Yamamoto, Y.; Murosaki, S. Effects of hot water extract of Curcuma longa on human epidermal keratinocytes in vitro and skin conditions in healthy participants: A randomized, double-blind, placebo-controlled trial. J. Cosmet. Dermatol. 2019, 18, 1866–1874. [Google Scholar] [CrossRef] [PubMed]
  153. Kaur, C.D.; Saraf, S. Topical vesicular formulations of Curcuma longa extract on recuperating the ultraviolet radiation–damaged skin. J. Cosmet. Dermatol. 2011, 10, 260–265. [Google Scholar] [CrossRef]
  154. Dickmann, D.I.; Kuzovkina, J. Poplars and willows of the world, with emphasis on silviculturally important species. In Poplars and Willows: Trees for Society and the Environment; The Food and Agriculture Organization of the United Nations:: Rome, Italy; CABI: Wallingford, UK, 2014; pp. 8–91. [Google Scholar] [CrossRef]
  155. Javed, B.; Farooq, F.; Ibrahim, M.; Abbas, H.A.B.; Jawwad, H.; Zehra, S.S.; Nawaz, K. Antibacterial and antifungal activity of methanolic extracts of Salix alba L. against various disease causing pathogens. Braz. J. Biol. 2021, 83, e243332. [Google Scholar] [CrossRef]
  156. Andrei, M. Multiple natural approaches of Salix alba. Arch. Microbiol. Immunol. 2024, 8, 410–427. [Google Scholar] [CrossRef]
  157. Zheng, L.; Jacquier, J.C.; Harbourne, N. Preparation of polyphenol-rich herbal beverages from white willow (Salix alba) bark with potential Alzheimer’s disease inhibitory activity in silico. Beverages 2024, 10, 75. [Google Scholar] [CrossRef]
  158. Sulaiman, G.M.; Hussien, N.N.; Marzoog, T.R.; Awad, H.A. Phenolic content, antioxidant, antimicrobial and cytotoxic activities of ethanolic extract of Salix alba. Am. J. Biochem. Biotechnol. 2013, 9, 41–46. [Google Scholar] [CrossRef]
  159. Maloshtan, L.M.; Pidgaina, V.V. Pharmacological activity cream of extract Salix alba and zinc for allergic contact dermatitis. Farmatsevtychnyi Zhurnal 2022, 6, 68–74. [Google Scholar] [CrossRef]
  160. Maistro, E.L.; Terrazzas, P.M.; Perazzo, F.F.; Gaivão, I.O.N.D.M.; Sawaya, A.C.H.F.; Rosa, P.C.P. Salix alba (white willow) medicinal plant presents genotoxic effects in human cultured leukocytes. J. Toxicol. Environ. Health A 2019, 82, 1223–1234. [Google Scholar] [CrossRef] [PubMed]
  161. Grubov, V.I. (Ed.) Plants of Central Asia—Plant Collection from China and Mongolia Vol. 14A: Compositae (Anthemideae); CRC Press: Boca Raton, FL, USA, 2007. [Google Scholar] [CrossRef]
  162. Rakhimova, N.K.; Rakhimova, T.; Sadinov, J.S. Current state of Anabasis salsa pasture varieties in Karakalpak Ustyurt (Uzbekistan) due to Aral Sea drying. Plant Sci. Today 2022, 9, 25–30. [Google Scholar] [CrossRef]
  163. Berganayeva, G.; Kudaibergenova, B.; Litvinenko, Y.; Nazarova, I.; Sydykbayeva, S.; Vassilina, G.; Dyusebaeva, M. Medicinal plants of the flora of Kazakhstan used in the treatment of skin diseases. Molecules 2023, 28, 4192. [Google Scholar] [CrossRef]
  164. Ydyrys, A.; Zhamanbayeva, G.; Zhaparkulova, N.; Aralbaeva, A.; Askerbay, G.; Kenzheyeva, Z.; Murzakhmetova, M. The systematic assessment of the membrane-stabilizing and antioxidant activities of several Kazakhstani plants in the Asteraceae family. Plants 2023, 13, 96. [Google Scholar] [CrossRef]
  165. Hosseini, S.H.; Hosseini, S.V.; Mohammadi, M.; Ahmadyousefi, M. Asteraceae family: Phytochemical composition, pharmacological effects and traditional uses. Res. Ethnobiol. Conserv. 2024, 1, 63–86. [Google Scholar]
  166. Dyusebaeva, M.A.; Berillo, D.A.; Berganayeva, A.E.; Berganayeva, G.E.; Ibragimova, N.A.; Jumabayeva, S.M.; Vassilina, G.K. Antimicrobial activity of silver nanoparticles stabilized by liposoluble extract of Artemisia terrae-albae. Processes 2023, 11, 3041. [Google Scholar] [CrossRef]
  167. Ryabushkina, N.; Gemedjieva, N.; Kobaisy, M.; Cantrell, C.L. Brief review of Kazakhstan flora and use of its wild species. Asian Australas. J. Plant Sci. Biotechnol. 2008, 2, 64–71. [Google Scholar]
  168. Turuspekov, Y.; Genievskaya, Y.; Baibulatova, A.; Zatybekov, A.; Kotuhov, Y.; Ishmuratova, M.; Abugalieva, S. Phylogenetic taxonomy of Artemisia, L. species from Kazakhstan based on matK analyses. Proc. Latv. Acad. Sci. 2018, 72, 29. [Google Scholar] [CrossRef]
  169. Sagyndykova, M.; Imanbayeva, A.; Gassanova, G.; Ishmuratova, M. Current Status and Resources of Alhagi pseudalhagi (Fabaceae) in the Atyrau Region, Western Kazakhstan. Diversity 2024, 16, 219. [Google Scholar] [CrossRef]
Figure 1. Structural formula of arbutin—the main bioactive phenolic glycoside of Bergenia crassifolia.
Figure 1. Structural formula of arbutin—the main bioactive phenolic glycoside of Bergenia crassifolia.
Molecules 30 03281 g001
Figure 2. Phytotherapeutic application and chemical composition of Bergenia crassifolia.
Figure 2. Phytotherapeutic application and chemical composition of Bergenia crassifolia.
Molecules 30 03281 g002
Figure 3. Structural formula of rutin—a key flavonoid component found in Sambucus nigra flowers and Solidago canadensis.
Figure 3. Structural formula of rutin—a key flavonoid component found in Sambucus nigra flowers and Solidago canadensis.
Molecules 30 03281 g003
Figure 4. Structural formula of aucubin, the main bioactive iridoid glycoside found in Plantago major.
Figure 4. Structural formula of aucubin, the main bioactive iridoid glycoside found in Plantago major.
Molecules 30 03281 g004
Figure 5. Phytotherapeutic application and chemical composition of Solidago canadensis.
Figure 5. Phytotherapeutic application and chemical composition of Solidago canadensis.
Molecules 30 03281 g005
Figure 6. Phytotherapeutic application and chemical composition of Tussilago farfara.
Figure 6. Phytotherapeutic application and chemical composition of Tussilago farfara.
Molecules 30 03281 g006
Figure 7. Structural formula of deoxycholic acid—a secondary bile acid with surfactant and lipolytic properties used in pharmaceutical and cosmetic formulations.
Figure 7. Structural formula of deoxycholic acid—a secondary bile acid with surfactant and lipolytic properties used in pharmaceutical and cosmetic formulations.
Molecules 30 03281 g007
Figure 8. Structural formula of ellagic acid, the main biologically active compound in Rubus spp.
Figure 8. Structural formula of ellagic acid, the main biologically active compound in Rubus spp.
Molecules 30 03281 g008
Figure 9. Phytotherapeutic application and chemical composition of Rubus vulgaris.
Figure 9. Phytotherapeutic application and chemical composition of Rubus vulgaris.
Molecules 30 03281 g009
Figure 10. Structural formula of taraxerol—one of the major triterpenoids found in Taraxacum officinale.
Figure 10. Structural formula of taraxerol—one of the major triterpenoids found in Taraxacum officinale.
Molecules 30 03281 g010
Figure 11. Structural formula of secoisolariciresinol diglucoside, the main lignan found in Linum usitatissimum.
Figure 11. Structural formula of secoisolariciresinol diglucoside, the main lignan found in Linum usitatissimum.
Molecules 30 03281 g011
Figure 12. Phytotherapeutic application and chemical composition of Viburnum opulus.
Figure 12. Phytotherapeutic application and chemical composition of Viburnum opulus.
Molecules 30 03281 g012
Figure 13. Structural formula of cyanidin-3-glucoside—a major anthocyanin found in Viburnum opulus.
Figure 13. Structural formula of cyanidin-3-glucoside—a major anthocyanin found in Viburnum opulus.
Molecules 30 03281 g013
Figure 14. Structural formula of imperatorin—a major furanocoumarin component found in Angelica archangelica.
Figure 14. Structural formula of imperatorin—a major furanocoumarin component found in Angelica archangelica.
Molecules 30 03281 g014
Figure 15. Phytotherapeutic application and chemical composition of Angelica archangelica.
Figure 15. Phytotherapeutic application and chemical composition of Angelica archangelica.
Molecules 30 03281 g015
Figure 16. Structural formula of arctigenin, the main biologically active lignan found in Arctium lappa.
Figure 16. Structural formula of arctigenin, the main biologically active lignan found in Arctium lappa.
Molecules 30 03281 g016
Figure 17. Structural formula of inulin—a natural fructan polysaccharide found in the roots of Inula helenium.
Figure 17. Structural formula of inulin—a natural fructan polysaccharide found in the roots of Inula helenium.
Molecules 30 03281 g017
Figure 18. Phytotherapeutic application and chemical composition of Althaea officinalis.
Figure 18. Phytotherapeutic application and chemical composition of Althaea officinalis.
Molecules 30 03281 g018
Figure 19. Structural formula of galacturonic acid, the principal structural unit of mucilaginous polysaccharides in Althaea officinalis.
Figure 19. Structural formula of galacturonic acid, the principal structural unit of mucilaginous polysaccharides in Althaea officinalis.
Molecules 30 03281 g019
Figure 20. Phytotherapeutic application and chemical composition of Lavandula angustifolia.
Figure 20. Phytotherapeutic application and chemical composition of Lavandula angustifolia.
Molecules 30 03281 g020
Figure 21. Structural formula of terpinen-4-ol—a key oxygenated monoterpene found in Lavandula angustifolia essential oil.
Figure 21. Structural formula of terpinen-4-ol—a key oxygenated monoterpene found in Lavandula angustifolia essential oil.
Molecules 30 03281 g021
Figure 22. Structural formula of biochanin A—a major isoflavone found in Trifolium pratense L.
Figure 22. Structural formula of biochanin A—a major isoflavone found in Trifolium pratense L.
Molecules 30 03281 g022
Figure 23. Phytotherapeutic application and chemical composition of Trifolium pratense.
Figure 23. Phytotherapeutic application and chemical composition of Trifolium pratense.
Molecules 30 03281 g023
Figure 24. Structural formula of gallic acid—a major phenolic acid found in Hamamelis virginiana.
Figure 24. Structural formula of gallic acid—a major phenolic acid found in Hamamelis virginiana.
Molecules 30 03281 g024
Figure 25. Structural formula of chlorogenic acid—a hydroxycinnamic acid found in Bromus inermis.
Figure 25. Structural formula of chlorogenic acid—a hydroxycinnamic acid found in Bromus inermis.
Molecules 30 03281 g025
Figure 26. Structural formula of curcumin—the principal bioactive compound of Curcuma longa.
Figure 26. Structural formula of curcumin—the principal bioactive compound of Curcuma longa.
Molecules 30 03281 g026
Figure 27. Structural formula of salicin—the primary phenolic glycoside found in Salix alba.
Figure 27. Structural formula of salicin—the primary phenolic glycoside found in Salix alba.
Molecules 30 03281 g027
Figure 28. Structural formula of artabsin, the main biologically active sesquiterpene lactone found in Artemisia terrae-albae.
Figure 28. Structural formula of artabsin, the main biologically active sesquiterpene lactone found in Artemisia terrae-albae.
Molecules 30 03281 g028
Table 1. Phytochemical composition and therapeutic uses of medicinal plants for dermatological conditions.
Table 1. Phytochemical composition and therapeutic uses of medicinal plants for dermatological conditions.
No.Plant SpeciesKey Bioactive CompoundsPharmacological ActivitiesDermatological ApplicationsReferences
1.1Bergenia crassifoliaArbutin, tannins, flavonoidsAnti-inflammatory, depigmenting, antimicrobialBurns, hyperpigmentation, inflammation[13,14,15,16,17,18,19]
1.2Sambucus nigraFlavonoids, anthocyanins, organic acidsAntioxidant, anti-inflammatory, antibacterialInflammation, anti-photoaging[22,23,24,25,27]
1.3Plantago majorAucubin, flavonoids, phenolic acidsAnti-inflammatory, wound-healing, antimicrobialWounds, burns, eczema[31,32,33,34,35]
1.4Solidago canadensisFlavonoids, saponins, essential oilsAnti-inflammatory, antioxidant, antimicrobialInflammation, eczema[36,37,38,39]
1.5Tussilago farfaraFlavonoids, phenolic acids, sesquiterpenesAnti-inflammatory, antioxidant, antimicrobialSkin irritations, acne, wounds[42,43,44,45,46]
1.6Rubus vulgarisAnthocyanins, ellagitannins, phenolic acidsAntioxidant, anti-inflammatory, antimicrobialEczema, psoriasis, acne[51,52,53,54]
1.7Taraxacum officinaleSesquiterpenes, flavonoids, phenolic acidsAnti-inflammatory, antioxidant, antimicrobialEczema, acne, inflammation[60,61,62,63,64]
1.8Linum usitatissimumLignans, phenolic acids, fatty acidsAnti-inflammatory, antioxidant, wound-healingBurns, eczema, dermatitis[68,69,70,71]
1.9Viburnum opulusFlavonoids, anthocyanins, tanninsAntioxidant, anti-inflammatory, antimicrobialInflammation, eczema, dermatitis[74,75,76,78,79]
1.10Angelica archangelicaFuranocoumarins, sesquiterpene lactonesAnti-inflammatory, antioxidant, antibacterialPsoriasis, inflammation, vitiligo[82,83,84,85,86,87,88]
1.11Arctium lappaLignans, phenolic acids, inulinAnti-inflammatory, antioxidant, antimicrobialDermatitis, acne, wounds[92,93,94,95,96]
1.12Inula heleniumInulin, sesquiterpene lactones, flavonoidsAnti-inflammatory, antioxidant, wound-healingEczema, dermatitis, psoriasis, wounds[99,100,102,103,104,105]
1.13Althaea officinalisPolysaccharides, flavonoids, tanninsAnti-inflammatory, emollient, antimicrobialEczema, psoriasis, inflammation[108,109,110,111,112,113]
1.14Lavandula angustifoliaTerpenoids, coumarins, essential oilsAnti-inflammatory, antibacterial, antioxidantAcne, eczema, inflammation[119,120,121]
1.15Trifolium pratenseIsoflavones, flavonoids, phenolic acidsAnti-inflammatory, antioxidant, antimicrobialAging skin, eczema, wounds[125,126,127,128,129]
1.16Hamamelis virginianaTannins, flavonoids, gallic acidAstringent, anti-inflammatory, antioxidantOily skin, acne, inflammation[132,133,136,137]
1.17Bromus inermisPhenolic acids, coumarins, essential oilsAnti-inflammatory, antioxidant, antimicrobialAcne, dermatitis, inflammation[141,142]
1.18Curcuma longaCurcuminoids, sesquiterpenoids, essential oilsAnti-inflammatory, antioxidant, antimicrobialAcne, eczema, inflammation, anti-photoaging[145,148,149,150,151,152,153]
1.19Salix albaSalicin, flavonoids, phenolic acidsAnti-inflammatory, antioxidant, antimicrobialAcne, dermatitis, inflammation[156,157,158,159,160]
1.20Artemisia terrae-albaeSesquiterpenes, flavonoids, phenolic acidsAnti-inflammatory, antioxidant, antimicrobialDermatitis, eczema, psoriasis, inflammation[164,165,166,167,168,169]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bolatkyzy, N.; Shepilov, D.; Turmanov, R.; Berillo, D.; Vassilina, T.; Ibragimova, N.; Berganayeva, G.; Dyusebaeva, M. Medicinal Plants for Skin Disorders: Phytochemistry and Pharmacological Insights. Molecules 2025, 30, 3281. https://doi.org/10.3390/molecules30153281

AMA Style

Bolatkyzy N, Shepilov D, Turmanov R, Berillo D, Vassilina T, Ibragimova N, Berganayeva G, Dyusebaeva M. Medicinal Plants for Skin Disorders: Phytochemistry and Pharmacological Insights. Molecules. 2025; 30(15):3281. https://doi.org/10.3390/molecules30153281

Chicago/Turabian Style

Bolatkyzy, Nazerke, Daniil Shepilov, Rakhymzhan Turmanov, Dmitriy Berillo, Tursunay Vassilina, Nailya Ibragimova, Gulzat Berganayeva, and Moldyr Dyusebaeva. 2025. "Medicinal Plants for Skin Disorders: Phytochemistry and Pharmacological Insights" Molecules 30, no. 15: 3281. https://doi.org/10.3390/molecules30153281

APA Style

Bolatkyzy, N., Shepilov, D., Turmanov, R., Berillo, D., Vassilina, T., Ibragimova, N., Berganayeva, G., & Dyusebaeva, M. (2025). Medicinal Plants for Skin Disorders: Phytochemistry and Pharmacological Insights. Molecules, 30(15), 3281. https://doi.org/10.3390/molecules30153281

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop